dextromethorphan HBr 40 MG per 5 ML Syrup

dextromethorphan hydrobromide 8 MG/ML Oral Solution


dextromethorphan hydrobromide 3.5 MG per 5 ML Syrup

dextromethorphan hydrobromide 0.7 MG/ML Oral Solution


dibucaine 1 % Topical Ointment
dibucaine 0.01 MG/MG Topical Ointment

dibucaine 1 GM per 100 GM Topical Ointment.


diphenhydrAMINE hydrochloride 1 % Topical Cream

diphenhydramine hydrochloride 1 % Topical Cream

diphenhydrAMINE hydrochloride 10 MG/ML Topical Cream

diphenhydramine hydrochloride 10 MG/ML Topical Cream


DOSS Sodium 50 MG Oral Capsule
docusate sodium 50 MG Oral Capsule


dyclonine hydrochloride 2 MG Oral Lozenge


dyclonine hydrochloride 3 MG Oral Lozenge


dyclonine hydrochloride 1.2 MG Oral Lozenge


ferrous fumarate 325 MG (iron 106 MG) Oral Tablet


ferrous gluconate 300 MG (iron 35 MG) Oral Tablet


ferrous gluconate 324 MG (iron 38 MG) Oral Tablet


ferrous sulfate 300 MG Oral Tablet
FESO4 300 MG Oral Tablet

ferrous sulfate 300 MG (iron 60 MG) Oral Tablet


folic acid 400 MCG Oral Tablet
folate 0.4 MG Oral Tablet


folate 0.8 MG Oral Tablet
folic acid 800 MCG Oral Tablet


glucose 15 GM per 37.5 GM Oral Gel
dextrose 40 % Oral Gel
glucose 32 GM per 80 GM Oral Gel
glucose 18 GM per 45 GM Oral Gel


hexylresorcinol 1 MG/ML Topical Solution


kaolin 5.8 GM / pectin 130 MG in 30 mL Oral Suspension

kaolin 5.8 GM / pectin 130 MG per 30 ML Oral Suspension

kaolin 193 MG/ML / pectin 4.33 MG/ML Oral Suspension


benzalkonium Cl 0.13 % / lidocaine HCl 2.5 % Topical Spray

benzalkonium chloride 1.3 MG/ML / lidocaine hydrochloride 25 MG/ML Topical Spray


loperamide hydrochloride 2 MG Oral Tablet


magnesium oxide 400 MG (magnesium 240 MG) Oral Tablet


magnesium salicylate 580 MG (as magnesium salicylate anhydrous 467 MG) Oral Tablet


methylene blue 20 MG/ML Topical Solution


methyl salicylate 100 MG/ML Topical Lotion


miconazole nitrate 100 MG Vaginal Insert


naphazoline HCl 0.03 % Ophthalmic Solution

naphazoline hydrochloride 0.03 % Ophthalmic Solution

naphazoline hydrochloride 0.3 MG/ML Ophthalmic Solution


naphazoline hydrochloride 0.5 MG/ML Nasal Spray


naproxen sodium 220 MG (as naproxen 200 MG) Oral Tablet


niacin 100 MG Oral Tablet
nicotinic acid 100 MG Oral Tablet
vitamin B3 100 MG Oral Tablet


vitamin B3 50 MG Oral Tablet
niacin 50 MG Oral Tablet
nicotinic acid 50 MG Oral Tablet
vit-B3 50 MG Oral Tablet


phenylephrine hydrochloride 0.25 % Nasal Spray

phenylephrine hydrochloride 2.5 MG/ML Nasal Spray


polysaccharide iron complex 100 MG per 5 mL Oral Solution

polysaccharide iron complex 100 MG per 5 ML Elixir

polysaccharide iron complex 20 MG/ML Oral Solution


polysaccharide iron complex (as iron) 150 MG Oral Capsule

polysaccharide iron complex 150 MG Oral Capsule


polysaccharide iron complex 150 MG Oral Tablet


Pot Chloride 1.33 MEQ Oral Tablet
potassium chloride 1.33 MEQ Oral Tablet
K+ Chloride 1.33 MEQ Oral Tablet
potassium chloride 99 MG Oral Tablet


potassium gluconate 550 MG (potassium ion 92 MG) Oral Tablet

potassium gluconate 2.35 MEQ Oral Tablet


povidone-iodine 0.01 MG/MG Topical Ointment


pramoxine hydrochloride 1 % Topical Lotion

pramoxine hydrochloride 10 MG/ML Topical Lotion


pseudoephedrine hydrochloride 30 MG Oral Tablet


chlorpheniramine maleate 1 MG / pseudoephedrine HCl 15 MG per 5 mL Oral Solution

chlorpheniramine maleate 1 MG / pseudoephedrine HCl 15 MG per 5 ML Oral Solution

chlorpheniramine maleate 0.2 MG/ML / pseudoephedrine hydrochloride 3 MG/ML Oral Solution


quiNINE 200 MG Oral Capsule
quiNINE sulfate 200 MG Oral Capsule


salicylic acid 2 % Topical Swab
salicylic acid 2 % Medicated Pad


salicylic acid 50 MG/ML Topical Solution


selenium sulfide 1 % Medicated Shampoo
selenium sulfide 1 % Lotion Shampoo

selenium sulfide 10 MG/ML Medicated Shampoo


dimethicone 125 MG Oral Capsule
simethicone 125 MG Oral Capsule


simethicone 20 MG in 0.3 mL Oral Suspension

simethicone 40 MG per 0.6 ML Oral Suspension

simethicone 20 MG per 0.3 ML Oral Suspension


sodium bicarbonate 324 MG Oral Tablet
sodium bicarbonate 325 MG Oral Tablet
NaHCO3 325 MG Oral Tablet


sodium bicarbonate 10 Grains Oral Tablet


calcium 145 MG / fluoride 3.75 MG Oral Capsule, as calcium carbonate and sodium fluoride

calcium carbonate 364 MG / sodium fluoride 8.3 MG Oral Capsule


calcium 145 MG / fluoride 3.75 MG Oral Tablet, as calcium carbonate and sodium fluoride

calcium carbonate 364 MG / sodium fluoride 8.3 MG Oral Tablet


trolamine salicylate 10 % Topical Ointment

trolamine salicylate 0.1 MG/MG Topical Ointment


triethanolamine salicylate 10 % Topical Gel

trolamine salicylate 0.1 MG/MG Topical Gel


urea 20 % Topical Cream
urea 17 GM in 85 GM Topical Cream


cyanocobalamin 2500 MCG Sublingual Tablet


ascorbic acid 1500 MG Oral Tablet
vit-C 1500 MG Oral Tablet
vitamin C 1500 MG Oral Tablet


vitamin C 100 MG Oral Tablet
vit-C 100 MG Oral Tablet
ascorbic acid 100 MG Oral Tablet


vit-C 500 MG Oral Capsule
vitamin C 500 MG Oral Capsule
ascorbic acid 500 MG Oral Capsule


vitamin C 1 GM Oral Tablet
ascorbic acid 1000 MG Oral Tablet
vit-C 1000 MG Oral Tablet
vitamin C 1000 MG Oral Tablet


phytonadione 0.1 MG Oral Tablet
vitamin K 100 MCG Oral Tablet


xylometazoline hydrochloride 1 MG/ML Nasal Spray


zinc oxide 0.2 MG/MG Topical Ointment
ZNO 0.2 MG/MG Topical Ointment
zinc oxide 20 % Topical Ointment

zinc oxide 200 MG per GM Topical Ointment


zinc sulfate 0.25 % Ophthalmic Solution
ZnSO4 2.5 MG/ML Ophthalmic Solution

zinc sulfate 2.5 MG/ML Ophthalmic Solution


zinc sulfate 66 MG (zinc 15 MG) Oral Tablet


ePHEDrine sulfate 2.5 MG/ML Nasal Spray
ePHEDrine sulfate 0.25 % Nasal Spray
ephedrine sulfate 0.25 % Nasal Spray


chlorophyllin copper complex 100 MG Oral Tablet


magnesium lactate 7 MEQ Extended Release Oral Tablet

magnesium lactate 84 MG Extended Release Oral Tablet


pyridoxine HCl 100 MG Oral Tablet
vitamin B6 100 MG Oral Tablet


pyridoxine HCl 200 MG Extended Release Oral Tablet

vitamin B6 200 MG Extended Release Oral Tablet


pyridoxine 250 MG Oral Tablet
pyridoxine HCl 250 MG Oral Tablet


bismuth tribromophenate 3 % Topical Ointment

bismuth tribromophenate 0.03 MG/MG Topical Ointment


diphenhydrAMINE HCl 2 % / menthol 1 % Topical Spray

diphenhydrAMINE hydrochloride 2 % / menthol 1 % Topical Spray

diphenhydrAMINE hydrochloride 20 MG/ML / menthol 10 MG/ML Topical Spray

diphenhydramine hydrochloride 2 % / menthol 1 % Topical Spray

diphenhydramine hydrochloride 20 MG/ML / menthol 10 MG/ML Topical Spray


magnesium hydroxide 50 MG / malic acid 200 MG Oral Tablet

millk of magnesia 50 MG / malic acid 200 MG Oral Tablet


ferrous sulfate 159 MG Extended Release Oral Tablet

FESO4 159 MG Extended Release Oral Tablet

ferrous sulfate 159 MG (iron 45 MG) Extended Release Oral Tablet


PEG 400 1 % / tetrahydrozoline hydrochloride 0.05 % Ophthalmic Solution

polyethylene glycol 400 1 % / tetrahydrozoline HCl 0.05 % Ophthalmic Solution

polyethylene glycol 400 10 MG/ML / tetrahydrozoline hydrochloride 0.5 MG/ML Ophthalmic Solution


benzocaine 5 % / chloroxylenol 0.1 % Topical Ointment

benzocaine 0.05 MG/MG / chloroxylenol 0.001 MG/MG Topical Ointment


benzocaine 5 % / chloroxylenol 0.6 % Topical Spray

benzocaine 50 MG/ML / chloroxylenol 6 MG/ML Topical Spray


hydrogen peroxide 15 MG/ML Oral Solution


hydrogen peroxide 1.5 % Mucous Membrane Topical Gel


chlorpromazine (as chlorpromazine hydrochloride) 100 MG Rectal Suppository

chlorproMAZINE 100 MG Rectal Suppository

chlorproMAZINE (as chlorproMAZINE hydrochloride) 100 MG Rectal Suppository

chlorpromazine 100 MG Rectal Suppository


chlorproMAZINE (as chlorproMAZINE hydrochloride) 25 MG Rectal Suppository

chlorpromazine (as chlorpromazine hydrochloride) 25 MG Rectal Suppository


doxycycline monohydrate 100 MG Oral Capsule


doxycycline monohydrate 50 MG Oral Capsule


calamine 140 MG/ML / diphenhydrAMINE hydrochloride 20 MG/ML Topical Cream

calamine 14 % / diphenhydrAMINE HCl 2 % Topical Cream

calamine 14 % / diphenhydramine hydrochloride 2 % Topical Cream

calamine 14 % / diphenhydrAMINE hydrochloride 2 % Topical Cream

calamine 140 MG/ML / diphenhydramine hydrochloride 20 MG/ML Topical Cream


benzocaine 20 % / compound benzoin tincture 0.5 % Mucous Membrane Topical Solution

benzocaine 20 % / compound benzoin tincture (USP) 0.5 % Mucous Membrane Topical Solution

benzocaine 200 MG/ML / compound benzoin tincture (USP) 5 MG/ML Mucous Membrane Topical Solution


diphenhydrAMINE hydrochloride 1.25 MG/ML Oral Solution

diphenhydrAMINE HCl 50 MG in 40 mL Oral Solution

diphenhydramine hydrochloride 50 MG per 40 ML Oral Solution

diphenhydrAMINE hydrochloride 50 MG per 40 ML Oral Solution

diphenhydramine hydrochloride 1.25 MG/ML Oral Solution


PENTobarbital sodium 3.64 MG/ML Oral Solution

pentobarbital sodium 3.64 MG/ML Oral Solution


mycophenolate mofetil 250 MG Oral Capsule


ascorbic acid 250 MG Oral Tablet
vit-C 250 MG Oral Tablet
vitamin C 250 MG Oral Tablet


zinc oxide 10 % Topical Ointment
ZNO 0.1 MG/MG Topical Ointment


lidocaine 0.02 MG/MG / menthol 0.01 MG/MG Topical Gel


pyrantel pamoate 144 MG in 1 mL Oral Suspension

pyrantel pamoate 144 MG per 1 ML Oral Suspension

pyrantel pamoate 144 MG/ML (pyrantel base 50 MG/ML) Oral Suspension

pyrantel pamoate 144 MG/ML Oral Suspension


amiodarone hydrochloride 450 MG per 9 ML Injectable Solution

amiodarone hydrochloride 900 MG per 18 ML Injectable Solution

amiodarone hydrochloride 50 MG/ML Injectable Solution

amiodarone HCl 50 MG/ML Injectable Solution


rimexolone 10 MG/ML Ophthalmic Suspension


testosterone 2.5 MG/Day 24 HR Transdermal Patch

testosterone 2.5 MG/Day 24HR Transdermal System

testosterone 0.104 MG/HR 24 HR Transdermal Patch

24 HR testosterone 0.104 MG/HR Transdermal System


omeprazole 10 MG Delayed Release Oral Capsule

omeprazole (as omeprazole magnesium) 10 MG Delayed Release Oral Capsule


liothyronine sodium 0.01 MG per 1 ML Injection

liothyronine sodium 10 MCG per 1 ML Injection

liothyronine sodium 10 MCG in 1 ML Injection

1 ML liothyronine sodium 0.01 MG/ML Injection


vit-C 250 MG / Vitamin E 200 UNT Oral Tablet

vitamin C 250 MG / vitamin E 200 UNT Oral Tablet

ascorbic acid 250 MG / vitamin E 200 UNT Oral Tablet


pseudoephedrine hydrochloride 30 MG Oral Capsule


niacin 250 MG Oral Tablet
vitamin B3 250 MG Oral Tablet
vit-B3 250 MG Oral Tablet
nicotinic acid 250 MG Oral Tablet


lamiVUDine 150 MG Oral Tablet
3TC 150 MG Oral Tablet


lamivudine 10 MG per 1 ML Oral Solution
lamiVUDine 10 MG in 1 mL Oral Solution
3TC 10 MG/ML Oral Solution
lamiVUDine 10 MG per 1 ML Oral Solution
lamiVUDine 10 MG/ML Oral Solution


alpha-tocopherol 1 UNT / ubidecarenone 300 MG Oral Capsule

coenzyme Q10 30 MG / vitamin E 1 UNT Oral Capsule

ubidecarenone 30 MG / vitamin E 1 UNT Oral Capsule


salicylic acid 176 MG/ML Topical Solution


ubiquinone 50 MG Oral Capsule
ubidecarenone 50 MG Oral Capsule
coenzyme Q10 50 MG Oral Capsule


melatonin 2.5 MG / vitamin B6 0.5 MG Sublingual Tablet


melatonin 3 MG / vitamin B6 1 MG Oral Tablet


melatonin 5 MG / vitamin B6 1 MG Oral Tablet

melatonin 5 MG / pyridoxine 1 MG Oral Tablet


cyanocobalamin 5000 MCG Sublingual Tablet


chlorpheniramine maleate 4 MG / phenylephrine HCl 20 MG / phenyltoloxamine citrate 40 MG Extended Release Oral Tablet

chlorpheniramine maleate 4 MG / phenylephrine hydrochloride 20 MG / phenyltoloxamine citrate 40 MG Extended Release Oral Tablet


oxyCODONE hydrochloride 5 MG Oral Capsule

oxycodone hydrochloride 5 MG Oral Capsule


cisatracurium (as cisatracurium besylate) 2 MG/ML Injectable Solution

cisatracurium 2 MG/ML Injectable Solution


cisatracurium besylate 200 MG in 20 ML Injection

cisatracurium (as cisatracurium besylate) 200 MG per 20 ML Injection

cisatracurium 200 MG per 20 ML Injection


salicylic acid 120 MG/ML Topical Solution


chlorpheniramine maleate 2 MG in 5 mL Oral Solution

chlorpheniramine maleate 2 MG per 5 ML Oral Solution

chlorpheniramine maleate 0.4 MG/ML Oral Solution


vitamin B 12 500 MCG / folic acid 400 MCG Oral Tablet

folate 0.4 MG / vitamin B12 0.5 MG Oral Tablet

cyanocobalamin 500 MCG / folic acid 400 MCG Oral Tablet

folic acid 0.4 MG / vitamin B12 0.5 MG Oral Tablet


ritonavir 80 MG per 1 ML Oral Solution
ritonavir 80 MG in 1 mL Oral Solution


manganese gluconate 50 MG (manganese 5.7 MG) Oral Tablet


phenazopyridine hydrochloride 97.2 MG Oral Tablet


amphotericin B 100 MG/ML Oral Suspension


NaCl 0.154 MEQ/ML Topical Solution
sodium chloride 0.9 % Topical Solution

sodium chloride 0.154 MEQ/ML Topical Solution


quiNINE bisulfate 300 MG Oral Tablet
quiNINE 300 MG Oral Tablet


nortriptyline (as nortriptyline hydrochloride) 10 MG Oral Tablet


dicyclomine hydrochloride 10 MG Oral Tablet


VP-16 100 MG Oral Capsule
etoposide 100 MG Oral Capsule


fluorouracil (as fluorouracil sodium) 25 MG/ML Injectable Solution

5-5-fluorouracil 25 MG/ML Injectable Solution


folate 5 MG Oral Tablet
folic acid 5 MG Oral Tablet


LiCO3 250 MG Oral Tablet
lithium carbonate 250 MG Oral Tablet


mexiletine hydrochloride 50 MG Oral Capsule


promethazine hydrochloride 10 MG Oral Tablet


acetaminophen 500 MG / HYDROcodone bitartrate 10 MG Oral Tablet

HYDROcodone bitartrate 10 MG / acetaminophen 500 MG Oral Tablet

APAP 500 MG / hydrocodone bitartrate 10 MG Oral Tablet

APAP 500 MG / HYDROcodone bitartrate 10 MG Oral Tablet

acetaminophen 500 MG / hydrocodone bitartrate 10 MG Oral Tablet


selegiline hydrochloride 5 MG Oral Capsule


lidocaine hydrochloride 4 % Topical Gel
lidocaine HCl 4 % Topical Gel

lidocaine hydrochloride 0.04 MG/MG Topical Gel


cholecalciferol 0.025 MG Oral Tablet
vitamin D3 1000 UNT Oral Tablet
vitamin D3 25 MCG Oral Tablet

cholecalciferol 25 MCG (1000 UNT) Oral Tablet


vitamin B12 100 MCG Oral Lozenge
cyanocobalamin 0.1 MG Oral Lozenge


cyanocobalamin 0.5 MG Oral Lozenge
vitamin B12 500 MCG Oral Lozenge
cyanocobalamin 500 MCG Oral Lozenge


sodium phenylbutyrate 500 MG Oral Tablet


ciprofloxacin (as ciprofloxacin hydrochloride) 100 MG Oral Tablet


chlorophyllin copper complex 33.3 MG Oral Tablet


cyanocobalamin 0.25 MG Oral Lozenge
vitamin B12 250 MCG Oral Lozenge


potassium citrate 540 MG Extended Release Oral Tablet

K+ citrate 5 MEQ Extended Release Oral Tablet

Pot citrate 5 MEQ Extended Release Oral Tablet

potassium citrate 5 MEQ Extended Release Oral Tablet


12 HR carBAMazepine 100 MG Extended Release Oral Tablet

carBAMazepine 100 MG 12 HR Extended Release Oral Tablet

carBAMazepine 100 MG 12HR Extended Release Oral Tablet

carbamazepine 100 MG 12 HR Extended Release Oral Tablet

12 HR carbamazepine 100 MG Extended Release Oral Tablet


K+ citrate 10 MEQ Extended Release Oral Tablet

potassium citrate 1080 MG Extended Release Oral Tablet

Pot citrate 10 MEQ Extended Release Oral Tablet

potassium citrate 10 MEQ Extended Release Oral Tablet


risperiDONE 1 MG per 1 ML Oral Solution
risperiDONE 1 MG/ML Oral Solution
risperidone 1 MG per 1 ML Oral Solution
risperiDONE 1 MG in 1 mL Oral Solution


cidofovir 375 MG in 5 ML Injection
cidofovir 375 MG per 5 ML Injection


irinotecan HCl 40 MG in 2 ML Injection
irinotecan HCl 40 MG per 2 ML Injection

2 ML irinotecan hydrochloride 20 MG/ML Injection


buspirone hydrochloride 15 MG (buspirone 13.7 MG) Oral Tablet

busPIRone hydrochloride 15 MG (busPIRone 13.7 MG) Oral Tablet

busPIRone hydrochloride 15 MG Oral Tablet

buspirone hydrochloride 15 MG Oral Tablet


brompheniramine maleate 4 MG / phenylephrine hydrochloride 10 MG per 5 ML Elixir

brompheniramine maleate 4 MG / phenylephrine HCl 10 MG in 5 mL Oral Solution

brompheniramine maleate 0.8 MG/ML / phenylephrine hydrochloride 2 MG/ML Oral Solution


diethylcarbamazine citrate 50 MG Oral Tablet


ePHEDrine hydrochloride 30 MG/ML Injectable Solution

ephedrine hydrochloride 30 MG/ML Injectable Solution


neostigmine methylsulfate 2.5 MG/mL Injectable Solution

neostigmine methylsulfate 2.5 MG/ML Injectable Solution


nortriptyline (as nortriptyline hydrochloride) 25 MG Oral Tablet


terbutaline sulfate 0.05 % Injectable Solution

terbutaline sulfate 0.5 MG/ML Injectable Solution


acycycloguanosine 0.03 MG/MG Ophthalmic Ointment

acyclovir 0.03 MG/MG Ophthalmic Ointment


benzyl benzoate 250 MG/ML Topical Lotion


butylscopolamine bromide 20 MG/ML Injectable Solution


butylscopolamine bromide 10 MG Oral Tablet


carbenoxolone sodium 2 % Oral Gel
carbenoxolone 2 % Oral Gel


valproate sodium 200 MG per 5 ML Syrup
VPA 40 MG/ML Oral Solution


flecainide acetate 10 MG/ML Injectable Solution


IDArubicin hydrochloride 10 MG Oral Capsule

idarubicin hydrochloride 10 MG Oral Capsule


IDArubicin hydrochloride 25 MG Oral Capsule

idarubicin hydrochloride 25 MG Oral Capsule


IDArubicin hydrochloride 5 MG Oral Capsule

idarubicin hydrochloride 5 MG Oral Capsule


medroxyPROGESTERone acetate 100 MG Oral Tablet

medroxyprogesterone acetate 100 MG Oral Tablet


medroxyPROGESTERone acetate 200 MG Oral Tablet

medroxyprogesterone acetate 200 MG Oral Tablet


medroxyPROGESTERone acetate 500 MG Oral Tablet

medroxyprogesterone acetate 500 MG Oral Tablet


mesalazine 250 MG Delayed Release Oral Tablet

mesalamine 250 MG Delayed Release Oral Tablet


mexiletine hydrochloride 25 MG/ML Injectable Solution


miconazole nitrate 0.02 MG/MG Topical Gel


niMODipine 0.2 MG/ML Injectable Solution

nimodipine 0.2 MG/ML Injectable Solution


pentosan polysulfate sodium 100 MG Oral Capsule

pentosan polysulfate 100 MG Oral Capsule


pralidoxime 25 MG/ML Injectable Solution


pyrilamine 2 % Topical Cream
pyrilamine maleate 2 % Topical Cream


sotalol hydrochloride 10 MG/ML Injectable Solution


acycycloguanosine 200 MG Oral Tablet
acyclovir 200 MG Oral Tablet


disopyramide (as disopyramide phosphate) 10 MG/ML Injectable Solution

disopyramide 10 MG/ML Injectable Solution


medroxyPROGESTERone acetate 250 MG Oral Tablet

medroxyprogesterone acetate 250 MG Oral Tablet


raNITIdine bismuth citrate 400 MG Oral Tablet


levodopa 50 MG / benserazide 12.5 MG Oral Capsule

Benserazide 12.5 MG / L-DOPA 50 MG Oral Capsule

benserazide 12.5 MG / levodopa 50 MG Oral Capsule


Benserazide 50 MG / L-DOPA 200 MG Oral Capsule

levodopa 200 MG / benserazide 50 MG Oral Capsule

benserazide 50 MG / levodopa 200 MG Oral Capsule


Benserazide 25 MG / L-DOPA 100 MG Oral Tablet

benserazide 25 MG / levodopa 100 MG Oral Tablet


evening primrose oil 500 MG Oral Capsule


testosterone undecanoate 40 MG Oral Capsule


tropisetron (as tropisetron hydrochloride) 1 MG/ML Injectable Solution


tropisetron (as tropisetron hydrochloride) 5 MG Oral Capsule


amiodarone hydrochloride 100 MG Oral Tablet


diclofenac sodium 100 MG Rectal Suppository


miconazole nitrate 20 MG/ML Topical Lotion


morphine sulfate 5 MG Extended Release Oral Tablet


naproxen sodium 750 MG 24HR Extended Release Oral Tablet

naproxen 750 MG (as naproxen sodium 825 MG) 24 HR Extended Release Oral Tablet

24 HR naproxen 750 MG Extended Release Oral Tablet


ferrous sulfate 325 MG Extended Release Oral Tablet

FESO4 324 MG Extended Release Oral Tablet

FESO4 325 MG Extended Release Oral Tablet


benzocaine 7.5 % Mucous Membrane Topical Solution

benzocaine 75 MG/ML Mucous Membrane Topical Solution


ubidecarenone 150 MG Oral Capsule
coenzyme Q10 150 MG Oral Capsule
ubiquinone 150 MG Oral Capsule


capsaicin 0.075 % / menthol 2 % Topical Cream

capsaicin 0.75 MG/ML / menthol 20 MG/ML Topical Cream


zidovudine 300 MG Oral Tablet
AZT 300 MG Oral Tablet


brompheniramine maleate 2 MG per 5 ML Oral Solution

brompheniramine maleate 0.4 MG/ML Oral Solution


acebutolol (as acebutolol HCl) 100 MG Oral Capsule


acebutolol (as acebutolol HCl) 400 MG Oral Tablet


amoxicillin 167 MG/ML Injectable Solution


Benserazide 25 MG / L-DOPA 100 MG Oral Capsule

levodopa 100 MG / benserazide 25 MG Oral Capsule

benserazide 25 MG / levodopa 100 MG Oral Capsule


Benserazide 12.5 MG / L-DOPA 50 MG Oral Tablet

benserazide 12.5 MG / levodopa 50 MG Oral Tablet


cilazapril (as cilazapril monohydrate) 0.5 MG Oral Tablet


cilazapril (as cilazapril monohydrate) 2.5 MG Oral Tablet


cilazapril (as cilazapril monohydrate) 5 MG Oral Tablet


cloNIDine hydrochloride 0.025 MG Oral Tablet

clonidine hydrochloride 0.025 MG Oral Tablet


clopamide 5 MG / pindolol 10 MG Oral Tablet


demeclocycline hydrochloride 150 MG Oral Capsule


diclofenac sodium 25 MG Rectal Suppository


diclofenac sodium 50 MG Rectal Suppository


PGE2 0.5 MG Oral Tablet
dinoprostone 0.5 MG Oral Tablet


disopyramide (as disopyramide phosphate) 250 MG Extended Release Oral Tablet

disopyramide 250 MG Extended Release Oral Tablet


domperidone (as domperidone maleate) 10 MG Oral Tablet


enalapril maleate 20 MG / hydroCHLOROthiazide 12.5 MG Oral Tablet

enalapril maleate 20 MG / HCTZ 12.5 MG Oral Tablet

enalapril maleate 20 MG / hydrochlorothiazide 12.5 MG Oral Tablet


famotidine 20 MG per 50 ML Injection
50 ML famotidine 0.4 MG/ML Injection


flurbiprofen 200 MG Extended Release Oral Capsule


guanethidine 10 MG/ML Injectable Solution


isoniazid 100 MG / rifAMPin 150 MG Oral Tablet

rifAMPin 150 MG / isoniazid 100 MG Oral Tablet

INH 100 MG / rifAMPin 150 MG Oral Tablet

INH 100 MG / Rifampin 150 MG Oral Tablet

isoniazid 100 MG / rifampin 150 MG Oral Tablet


INH 150 MG / rifAMPin 300 MG Oral Tablet

rifAMPin 300 MG / isoniazid 150 MG Oral Tablet

isoniazid 150 MG / rifAMPin 300 MG Oral Tablet

INH 150 MG / Rifampin 300 MG Oral Tablet

isoniazid 150 MG / rifampin 300 MG Oral Tablet


labetalol hydrochloride 400 MG Oral Tablet


labetalol hydrochloride 50 MG Oral Tablet


LiCO3 400 MG Extended Release Oral Tablet

lithium carbonate 400 MG Extended Release Oral Tablet


medroxyPROGESTERone acetate 400 MG Oral Tablet

medroxyprogesterone acetate 400 MG Oral Tablet


methotrimeprazine maleate 25 MG Oral Tablet


mexiletine HCl 360 MG Extended Release Oral Capsule

mexiletine hydrochloride 360 MG Extended Release Oral Capsule


morphine sulfate 20 MG Oral Tablet
MS 20 MG Oral Tablet


oxprenolol 160 MG Extended Release Oral Tablet


phentolamine 10 MG/ML Injectable Solution


prazosin (as prazosin HCl) 0.5 MG Oral Tablet


prazosin (as prazosin HCl) 1 MG Oral Tablet


prazosin (as prazosin HCl) 2 MG Oral Tablet


prazosin (as prazosin HCl) 5 MG Oral Tablet


promethazine hydrochloride 5 MG per 5 ML Elixir

promethazine hydrochloride 1 MG/ML Oral Solution


propranolol hydrochloride 160 MG Oral Tablet


theophylline 175 MG Extended Release Oral Tablet


disopyramide (as disopyramide phosphate) 150 MG Extended Release Oral Tablet

disopyramide 150 MG Extended Release Oral Tablet


ergocalciferol 10 MCG (400 UNT) Oral Tablet


vitamin C 10 % Topical Cream
ascorbic acid 10 % Topical Cream
vitamin C 100 MG/ML Topical Cream
vit-C 100 MG/ML Topical Cream


vit-C 15 MG / Bromelains 500 MG Oral Capsule

vitamin C 15 MG / bromelains 500 MG Oral Capsule

ascorbic acid 15 MG / bromelains 500 MG Oral Capsule


10 ML doxorubicin hydrochloride liposome 2 MG/ML Injection

10 ML DOXOrubicin hydrochloride liposome 2 MG/ML Injection

DOXOrubicin HCl liposome 20 MG in 10 ML Injection

DOXOrubicin hydrochloride liposome 20 MG per 10 ML Injection

doxorubicin hydrochloride liposome 20 MG per 10 ML Injection


triamcinolone acetonide 0.05 % Topical Ointment

triamcinolone acetonide 0.0005 MG/MG Topical Ointment


zinc oxide 12 % Topical Ointment
ZNO 0.12 MG/MG Topical Ointment


benzalkonium chloride 0.02 % Otic Solution


benzocaine 20 % / menthol 0.5 % Topical Spray

benzocaine 200 MG/ML / menthol 5 MG/ML Topical Spray


chromium nicotinic acid complex 200 MCG Oral Capsule

chromium nicotinic acid complex 0.2 MG Oral Capsule


levoFLOXacin (as levoFLOXacin hemihydrate) 250 MG Oral Tablet

levofloxacin (as levofloxacin hemihydrate) 250 MG Oral Tablet


levofloxacin 500 MG per 100 ML Injection

levoFLOXacin 500 MG per 100 ML Injection


Magnesium Aspartate 60 MG / K+ Aspartate 60 MG Oral Capsule

magnesium aspartate 60 MG / potassium aspartate 60 MG Oral Capsule

Magnesium Aspartate 60 MG / Pot Aspartate 60 MG Oral Capsule


bismuth formic iodide 16 % Topical Powder

bismuth-formic-iodide 0.16 MG/MG Topical Powder


hydroCHLOROthiazide 12.5 MG Oral Capsule

hydrochlorothiazide 12.5 MG Oral Capsule


pramoxine HCl 1 % / zinc acetate 0.1 % Topical Spray

pramoxine hydrochloride 10 MG/ML / zinc acetate 1 MG/ML Topical Spray


atorvastatin 10 MG Oral Tablet
atorvastatin calcium 10 MG Oral Tablet

atorvastatin (as atorvastatin calcium) 10 MG Oral Tablet


atorvastatin (as atorvastatin calcium) 20 MG Oral Tablet


propionic acid 2 % / undecylenic acid 5 % Topical Ointment

propionic acid 0.02 MG/MG / undecylenic acid 0.05 MG/MG Topical Ointment


albuterol (as albuterol sulfate) 0.5 MG/ML Injectable Solution


amoxicillin 200 MG/ML Injectable Solution


apomorphine 10 MG/ML Injectable Solution


cocaine 2 % / homatropine hydrobromide 2 % Ophthalmic Solution

cocaine 2 % / homatropine hydrobromide 2 % Ophthalmic Drops

cocaine (as cocaine hydrochloride) 20 MG/ML / homatropine hydrobromide 20 MG/ML Ophthalmic Solution

cocaine 20 MG/ML / homatropine hydrobromide 20 MG/ML Ophthalmic Solution


cilazapril (as cilazapril monohydrate) 1 MG Oral Tablet


framycetin 0.005 MG/MG Ophthalmic Ointment


haloperidol 10 MG/ML (as haloperidol lactate) Injectable Solution

haloperidol 10 MG/ML Injectable Solution


morphine sulfate 2 MG/ML Oral Suspension


morphine sulfate 3 MG/ML Oral Suspension


PHENobarbital 200 MG/ML Injectable Solution

phenobarbital 200 MG/ML Injectable Solution


sulfADIAZINE 250 MG/ML Injectable Solution

sulfadiazine 250 MG/ML Injectable Solution


verapamil hydrochloride 160 MG Oral Tablet


benzoyl peroxide 25 MG/ML Topical Lotion


Inositol 100 MG / nicotinic acid 400 MG Oral Capsule

inositol 100 MG / niacin 400 MG Oral Capsule

inositol 100 MG / vitamin B3 400 MG Oral Capsule

Inositol 100 MG / vit-B3 400 MG Oral Capsule


atorvastatin (as atorvastatin calcium) 40 MG Oral Tablet


dextromethorphan hydrobromide 0.667 MG/ML / guaifenesin 6.67 MG/ML Oral Solution

dextromethorphan hydrobromide 0.667 MG/ML / guaiFENesin 6.67 MG/ML Oral Solution

dextromethorphan HBr 10 MG / guaiFENesin 100 MG in 15 mL Oral Solution

dextromethorphan hydrobromide 20 MG / guaifenesin 200 MG per 30 ML Oral Solution

dextromethorphan hydrobromide 10 MG / guaiFENesin 100 MG per 15 ML Oral Solution

dextromethorphan hydrobromide 20 MG / guaiFENesin 200 MG per 30 ML Oral Solution

dextromethorphan hydrobromide 10 MG / guaifenesin 100 MG per 15 ML Oral Solution


biotin 800 MCG / calcium phosphate, dibasic 62 MG Oral Tablet

biotin 0.8 MG / dicalcium phosphate 62 MG Oral Tablet


scopolamine hydrobromide 0.4 MG Oral Tablet


mycophenolate mofetil 500 MG Oral Tablet


benzalkonium chloride 0.13 % / benzocaine 5 % Vaginal Cream

benzocaine 5 % / benzalkonium chloride 0.13 % Vaginal Cream

benzalkonium chloride 1.3 MG/ML / benzocaine 50 MG/ML Vaginal Cream


ferrous fumarate 89 MG (iron 29 MG) Oral Tablet


glucosamine sulfate 500 MG / chondroitin sulfate A 250 MG Oral Capsule

chondroitin sulfates 250 MG / glucosamine sulfate 500 MG Oral Capsule


lamiVUDine 150 MG / zidovudine 300 MG Oral Tablet

lamivudine 150 MG / zidovudine 300 MG Oral Tablet


mineral oil 14 % / petrolatum 71.9 % / phenylephrine hydrochloride 0.25 % Rectal Ointment

mineral oil 14 % / petrolatum 71.9 % / phenylephrine HCl 0.25 % Rectal Ointment

mineral oil 0.14 MG/MG / petrolatum 0.719 MG/MG / phenylephrine hydrochloride 0.0025 MG/MG Rectal Ointment


zinc oxide 6 % Topical Cream
ZNO 60 MG/ML Topical Cream


dehydroepiandrosterone 10 MG Oral Capsule


melatonin 2 MG Extended Release Oral Tablet


dolasetron mesylate 12.5 MG per 0.625 ML Injection

dolasetron mesylate 12.5 MG in 0.625 ML Injection

0.625 ML dolasetron mesylate 20 MG/ML Injection


saquinavir 200 MG (saquinavir mesylate) Oral Capsule


hydrocortisone 1 % / pramoxine HCl 1 % / chloroxylenol 0.1 % Topical Lotion

chloroxylenol 0.1 % / hydrocortisone 1 % / pramoxine hydrochloride 1 % Otic Lotion

chloroxylenol 1 MG/ML / hydrocortisone 10 MG/ML / pramoxine hydrochloride 10 MG/ML Topical Lotion

chloroxylenol 0.1 % / hydrocortisone 1 % / pramoxine hydrochloride 1 % Topical Lotion


glucosamine HCl 500 MG / chondroitin sulfate A 400 MG Oral Capsule

chondroitin sulfates 400 MG / glucosamine hydrochloride 500 MG Oral Capsule


benzalkonium chloride 0.11 % Topical Spray

benzalkonium chloride 1.1 MG/ML Topical Spray


carBAMazepine 300 MG 12HR Extended Release Oral Capsule

carBAMazepine 300 MG 12 HR Extended Release Oral Capsule

carbamazepine 300 MG 12 HR Extended Release Oral Capsule

12 HR carBAMazepine 300 MG Extended Release Oral Capsule

12 HR carbamazepine 300 MG Extended Release Oral Capsule


carBAMazepine 200 MG 12HR Extended Release Oral Capsule

12 HR carBAMazepine 200 MG Extended Release Oral Capsule

carBAMazepine 200 MG 12 HR Extended Release Oral Capsule

carbamazepine 200 MG 12 HR Extended Release Oral Capsule

12 HR carbamazepine 200 MG Extended Release Oral Capsule


FESO4 90 MG Oral Tablet
ferrous sulfate 90 MG Oral Tablet


salicylic acid 167 MG/ML Topical Solution


glucosamine hydrochloride 500 MG Oral Capsule


FIN5C 1 MG Oral Tablet
finasteride 1 MG Oral Tablet


camphor 0.5 % / menthol 0.5 % Topical Lotion

camphor 5 MG/ML / menthol 5 MG/ML Topical Lotion


ubiquinone 75 MG Oral Capsule
coenzyme Q10 75 MG Oral Capsule
ubidecarenone 75 MG Oral Capsule


benzethonium chloride 0.1 % Topical Spray

benzethonium chloride 1 MG/ML Topical Spray


glucosamine HCl 250 MG / chondroitin sulfates 200 MG Oral Tablet

chondroitin sulfates 200 MG / glucosamine hydrochloride 250 MG Oral Tablet


{4 (amoxicillin 500 MG Oral Capsule) / 2 (clarithromycin 500 MG Oral Tablet) / 2 (lansoprazole 30 MG Delayed Release Oral Capsule) } Pack

4 (amoxicillin 500 MG Oral Capsule) / 2 (clarithromycin 500 MG Oral Tablet) / 2 (lansoprazole 30 MG Delayed Release Oral Capsule) Pack


ASA 325 MG / diphenhydrAMINE Citrate 38 MG Oral Tablet

ASA 325 MG / Diphenhydramine Citrate 38 MG Oral Tablet

aspirin 325 MG / diphenhydrAMINE citrate 38 MG Oral Tablet

aspirin 325 MG / diphenhydramine citrate 38 MG Oral Tablet


fenoldopam 10 MG per 1 ML (as fenoldopam mesylate) Injection


montelukast 10 MG (as montelukast sodium 10.4 MG) Oral Tablet


liver derivative complex 25.5 MG/ML Injectable Solution


paregoric 2 MG (as morphine equivalent) per 5 ML Oral Solution

paregoric 2 MG (as morphine equivalent) in 5 mL Oral Solution


sevoflurane 1000 MG/ML Inhalation Solution


K+ phosphate 155 MG / Sodium Phosphate, Dibasic 852 MG / Sodium Phosphate, Monobasic 130 MG Oral Tablet

Pot phosphate 155 MG / Sodium Phosphate, Dibasic 852 MG / Sodium Phosphate, Monobasic 130 MG Oral Tablet

sodium phosphate, dibasic 852 MG / potassium phosphate, monobasic 155 MG / sodium phosphate, monobasic 130 MG Oral Tablet

potassium phosphate 155 MG / sodium phosphate, dibasic 852 MG / sodium phosphate, monobasic 130 MG Oral Tablet


desflurane 1000 MG/ML Inhalation Solution


amylases 20,000 UNT / endopeptidases 25,000 UNT / lipase 4500 UNT Oral Capsule

amylase 20,000 UNT / lipase 4500 UNT / protease 25,000 UNT Oral Capsule

amylase 20000 UNT / lipase 4500 UNT / protease 25000 UNT Oral Capsule


varicella-zoster virus vaccine live (Oka-Merck) strain 1350 PFU per 0.5 ML Injection

varicella virus vaccine live (VAR) 1350 PFU in 0.5 ML Injection

0.5 ML varicella-zoster virus vaccine live (Oka-Merck) strain 2700 UNT/ML Injection


hydroCHLOROthiazide 12.5 MG / valsartan 80 MG Oral Tablet

HCTZ 12.5 MG / valsartan 80 MG Oral Tablet

hydrochlorothiazide 12.5 MG / valsartan 80 MG Oral Tablet


valsartan 160 MG / hydroCHLOROthiazide 12.5 MG Oral Tablet

HCTZ 12.5 MG / valsartan 160 MG Oral Tablet

hydroCHLOROthiazide 12.5 MG / valsartan 160 MG Oral Tablet

hydrochlorothiazide 12.5 MG / valsartan 160 MG Oral Tablet


black widow spider antivenin 6000 UNT Injection

Latrodectus mactans antivenin 6000 UNT Injection


undecylenic acid 100 MG/ML Topical Spray


camphor 4.7 % / eucalyptus oil 1.2 % / menthol 2.6 % Topical Ointment

camphor 0.047 MG/MG / Eucalyptus oil 0.012 MG/MG / menthol 0.026 MG/MG Topical Ointment


capsaicin 0.025 % / trolamine salicylate 10 % Topical Cream

capsaicin 0.25 MG/ML / trolamine salicylate 100 MG/ML Topical Cream


soybean oil 100 MG/ML Injectable Suspension


soybean oil 200 MG/ML Injectable Suspension


soybean oil 300 MG/ML Injectable Suspension


paricalcitol 5 MCG/ML Injectable Solution

paricalcitol 5 MCG per 1 ML Injectable Solution

paricalcitol 0.005 MG/ML Injectable Solution

paricalcitol 10 MCG per 2 ML Injectable Solution


omeprazole 40 MG Delayed Release Oral Capsule


eptifibatide 20 MG per 10 ML Injection
eptifibatide 20 MG in 10 ML Injection


eptifibatide 75 MG per 100 ML Injection
eptifibatide 75 MG in 100 ML Injection

100 ML eptifibatide 0.75 MG/ML Injection


cyanocobalamin 115 MCG / folic acid 800 MCG / pyridoxine 10 MG Oral Tablet

folate 0.8 MG / vitamin B12 0.115 MG / vitamin B6 10 MG Oral Tablet

cyanocobalamin 0.115 MG / folic acid 0.8 MG / vitamin B6 10 MG Oral Tablet

folic acid 0.8 MG / vitamin B12 0.115 MG / vitamin B6 10 MG Oral Tablet


citalopram 20 MG (as citalopram HBr 24.99 MG) Oral Tablet


amantadine hydrochloride 100 MG Oral Tablet


A Chinese herbal medicine (CHM) containing the root of the perennial herbaceous plant Astragalus (Radix Astragali) belonging to the family Leguminosae. Huang Qi is believed to tonify Qi, induce diuresis, relieve edema and nourish blood. It may also replenish body fluids and help relieve pain.


spironolactone 50 MG Oral Tablet [Aldactone]


spironolactone 25 MG Oral Tablet [Aldactone]


spironolactone 100 MG Oral Tablet [Aldactone]


NDA020983 200 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler [Ventolin]

Ventolin HFA 0.09 MG/ACTUAT (albuterol sulfate 0.108 MG/ACTUAT from mouthpiece) Metered Dose Inhaler, 200 ACTUAT

Ventolin HFA 90 MCG/INHAL Metered Dose Inhaler, 200 Actuations

NDA020983 200 ACTUAT Ventolin 0.09 MG/ACTUAT Metered Dose Inhaler

Ventolin HFA 0.09 MG/ACTUAT Metered Dose Inhaler, 200 ACTUAT


Benadryl Allergy Liqui-Gel 25 MG Oral Capsule

diphenhydrAMINE hydrochloride 25 MG Oral Capsule [Benadryl]

Benadryl Dye-Free Allergy 25 MG Oral Capsule

diphenhydramine hydrochloride 25 MG Oral Capsule [Benadryl]


Panadol Extra Strength 500 MG Oral Tablet

acetaminophen 500 MG Oral Tablet [Panadol]


Zarontin 250 MG per 5 ML Oral Syrup
Zarontin 50 MG/ML Oral Solution
Zarontin 250 MG per 5 ML Oral Solution
Zarontin 250 MG in 5 mL Oral Solution

ethosuximide 50 MG/ML Oral Solution [Zarontin]


Motrin IB 200 MG Oral Tablet
Motrin 200 MG Oral Tablet


Sulfamylon 85 MG/ML Topical Cream
Sulfamylon 8.5 % Topical Cream

mafenide 85 MG/ML Topical Cream [Sulfamylon]


amphotericin B liposomal 50 MG Injection [AmBisome]


LaMICtal 5 MG Chewable Dispersible Tablet

lamoTRIgine 5 MG Chewable Tablet [LaMICtal]

lamotrigine 5 MG Chewable Tablet [Lamictal]


lamotrigine 25 MG Chewable Tablet [Lamictal]

LaMICtal 25 MG Chewable Dispersible Tablet

lamoTRIgine 25 MG Chewable Tablet [LaMICtal]


aMILoride hydrochloride 5 MG Oral Tablet [Midamor]

amiloride hydrochloride 5 MG Oral Tablet [Midamor]


Tambocor 50 MG Oral Tablet
TAMBOCOR 50 MG Oral Tablet

flecainide acetate 50 MG Oral Tablet [Tambocor]


Inderal LA 160 MG 24HR Extended Release Oral Capsule

24 HR Inderal LA 160 MG Extended Release Oral Capsule

Inderal LA 160 MG 24 HR Extended Release Oral Capsule

24 HR propranolol hydrochloride 160 MG Extended Release Oral Capsule [Inderal]


Inderal XL 80 MG 24 HR Extended Release Oral Capsule

24 HR propranolol hydrochloride 80 MG Extended Release Oral Capsule [Inderal]

Inderal LA 80 MG 24HR Extended Release Oral Capsule


metyroSINE 250 MG Oral Capsule [Demser]
Demser 250 MG Oral Capsule


Nitro-Dur 2.5 MG per 24HR Daily Transdermal Patch

Nitro-Dur 0.1 MG/HR 24HR Transdermal System

24 HR NTG 0.1 MG/HR Transdermal System [Nitro-Dur]

24 HR Nitro-Dur 0.1 MG/HR Transdermal System

24 HR TNG 0.1 MG/HR Transdermal System [Nitro-Dur]

24 HR nitroglycerin 0.1 MG/HR Transdermal System [Nitro-Dur]


24 HR TNG 0.2 MG/HR Transdermal System [Nitro-Dur]

Nitro-Dur 0.2 MG/HR 24HR Transdermal System

24 HR Nitro-Dur 0.2 MG/HR Transdermal System

Nitro-Dur 5 MG per 24HR Daily Transdermal Patch

24 HR NTG 0.2 MG/HR Transdermal System [Nitro-Dur]

24 HR nitroglycerin 0.2 MG/HR Transdermal System [Nitro-Dur]


24 HR TNG 0.2 MG/HR Transdermal System [Minitran]

Minitran 0.2 MG/HR 24 HR Transdermal Patch

24 HR Minitran 0.2 MG/HR Transdermal System

Minitran 0.2 MG/HR 24HR Transdermal System

24 HR NTG 0.2 MG/HR Transdermal System [Minitran]

24 HR nitroglycerin 0.2 MG/HR Transdermal System [Minitran]


24 HR NTG 0.4 MG/HR Transdermal System [Nitro-Dur]

Nitro-Dur 10 MG per 24HR Daily Transdermal Patch

24 HR Nitro-Dur 0.4 MG/HR Transdermal System

24 HR TNG 0.4 MG/HR Transdermal System [Nitro-Dur]

Nitro-Dur 0.4 MG/HR 24HR Transdermal System

24 HR nitroglycerin 0.4 MG/HR Transdermal System [Nitro-Dur]


24 HR NTG 0.4 MG/HR Transdermal System [Minitran]

24 HR TNG 0.4 MG/HR Transdermal System [Minitran]

24 HR Minitran 0.4 MG/HR Transdermal System

Minitran 0.4 MG/HR 24HR Transdermal System

Minitran 0.4 MG/HR 24 HR Transdermal Patch

24 HR nitroglycerin 0.4 MG/HR Transdermal System [Minitran]


Nitro-Dur 0.6 MG/HR 24HR Transdermal System

24 HR Nitro-Dur 0.6 MG/HR Transdermal System

24 HR NTG 0.6 MG/HR Transdermal System [Nitro-Dur]

24 HR TNG 0.6 MG/HR Transdermal System [Nitro-Dur]

Nitro-Dur 15 MG per 24HR Daily Transdermal Patch

24 HR nitroglycerin 0.6 MG/HR Transdermal System [Nitro-Dur]


secobarbital sodium 100 MG Oral Capsule [Seconal]


Amytal Sodium 0.5 GM Injection
Amytal 500 MG Injection
AMYTAL SODIUM 0.5 GM Injection

amobarbital sodium 500 MG Injection [Amytal]


1 ML Haldol 5 MG/ML Injection
Haldol 5 MG in 1 ML Injection
Haldol 5 MG per 1 ML Injection

1 ML haloperidol 5 MG/ML Injection [Haldol]


amitriptyline hydrochloride 25 MG Oral Tablet [Elavil]


clomiPRAMINE hydrochloride 25 MG Oral Capsule [Anafranil]

clomipramine hydrochloride 25 MG Oral Capsule [Anafranil]


clomiPRAMINE hydrochloride 50 MG Oral Capsule [Anafranil]

clomipramine hydrochloride 50 MG Oral Capsule [Anafranil]


isocarboxazid 10 MG Oral Tablet [Marplan]


dimenhyDRINATE 50 MG Oral Tablet [Dramamine]

dimenhydrinate 50 MG Oral Tablet [Dramamine]


ethosuximide 250 MG Oral Capsule [Zarontin]


Azactam 1 GM Injection
aztreonam 1000 MG Injection [Azactam]


vancomycin 125 MG Oral Capsule [Vancocin]

Vancocin (as vancomycin hydrochloride) 125 MG Oral Capsule


Vancocin (as vancomycin hydrochloride) 250 MG Oral Capsule

vancomycin 250 MG Oral Capsule [Vancocin]


CAPASTAT SULFATE 500 MG/ML Injectable Solution

capreomycin 500 MG/ML Injectable Solution [Capastat]


ethambutol hydrochloride 100 MG Oral Tablet [Myambutol]


ethambutol hydrochloride 400 MG Oral Tablet [Myambutol]


Rifadin 150 MG Oral Capsule
rifAMPin 150 MG Oral Capsule [Rifadin]


rifAMPin 300 MG Oral Capsule [Rifadin]
Rifadin 300 MG Oral Capsule


nitrofurantoin, macrocrystals 50 MG Oral Capsule [Macrodantin]


nitrofurantoin, macrocrystals 100 MG Oral Capsule [Macrodantin]


Diflucan 350 MG per 35 ML Oral Suspension

fluconazole 10 MG/ML Oral Suspension [Diflucan]


Diflucan 1400 MG per 35 ML Oral Suspension

Diflucan 200 MG per 5 ML Oral Suspension

fluconazole 40 MG/ML Oral Suspension [Diflucan]


acycycloguanosine 40 MG/ML Oral Suspension [Zovirax]

acyclovir 40 MG/ML Oral Suspension [Zovirax]


acycycloguanosine 400 MG Oral Tablet [Zovirax]


AZT 100 MG Oral Capsule [Retrovir]
RETROVIR 100 MG Oral Capsule
Retrovir 100 MG Oral Capsule

zidovudine 100 MG Oral Capsule [Retrovir]


Retrovir 50 MG per 5 ML Oral Syrup
RETROVIR 10 MG in 1 mL Oral Solution
AZT 10 MG/ML Oral Solution [Retrovir]
Retrovir 10 MG per 1 ML Oral Solution

zidovudine 10 MG/ML Oral Solution [Retrovir]


Daraprim 25 MG Oral Tablet
DARAPRIM 25 MG Oral Tablet

pyrimethamine 25 MG Oral Tablet [Daraprim]


medroxyPROGESTERone acetate 5 MG Oral Tablet [Provera]

medroxyprogesterone acetate 5 MG Oral Tablet [Provera]


medroxyPROGESTERone acetate 10 MG Oral Tablet [Provera]

medroxyprogesterone acetate 10 MG Oral Tablet [Provera]


Proscar 5 MG Oral Tablet
FIN5C 5 MG Oral Tablet [Proscar]


clomiPHENE citrate 50 MG Oral Tablet [Clomid]

clomiphene citrate 50 MG Oral Tablet [Clomid]


HESPAN 6 % in 500 ML Injection
500 ML Hespan 60 MG/ML Injection
Hespan 6 % per 500 ML Injection

500 ML hetastarch 60 MG/ML Injection [Hespan]


4-aminobenzoate 500 MG Oral Capsule [Potaba]


dantrolene sodium 25 MG Oral Capsule [Dantrium]


Dantrium 0.333 MG/ML (as dantrolene sodium) Injectable Solution

Dantrium 0.333 MG/ML Injectable Solution

dantrolene sodium 0.333 MG/ML Injectable Solution [Dantrium]


PREMARIN 1.25 MG Oral Tablet
Premarin 1.25 MG Oral Tablet

estrogens, conjugated (USP) 1.25 MG Oral Tablet [Premarin]


hydroxychloroquine sulfate 200 MG Oral Tablet [Plaquenil]


A sustained release transdermal patch containing the organic nitrate nitroglycerin, with vasodilator and potential immunomodulating activities. Upon application to the skin, nitroglycerin is continuously released from the patch and absorbed. In turn, nitroglycerin is converted into nitric oxide (NO), which activates guanylyl cyclase, increasing cyclic guanosine monophosphate concentration thus resulting in smooth muscle relaxation. In addition, activation of NO-mediated signaling pathways may inhibit hypoxia-induced tumor cell invasiveness, chemoresistance, evasion of immune cell recognition and cancer cell progression. Particularly, reactivation of NO-mediated signaling appears to inhibit the increased tumor cell shedding of the major histocompatibility complex class I chain-related (MIC) molecules MICA and MICB as is seen in hypoxic tumor environments; MIC molecules play key roles in tumor cell immune surveillance through their interaction with the C-type lectin-like NKG2D receptor on natural killer, lymphokine-activated killer and effector T cells.


The hydrochloride form of labetalol, a third generation selective alpha-1-adrenergic antagonist and non-selective beta-adrenergic antagonist with vasodilatory and antihypertensive properties. Labetalol competitively binds to alpha-1-adrenergic receptors in vascular smooth muscle, thereby inhibiting the adrenergic stimulation of endothelial cell function and vasoconstriction in peripheral blood vessels. This agent also binds to beta-receptors in the bronchial and vascular smooth muscle, resulting in a decrease in adrenergic stimulation. The result is a decrease in resting and exercise heart rates, cardiac output, and in both systolic and diastolic blood pressure, thereby resulting in vasodilation, and negative chronotropic and inotropic cardiac effects.


brand name of a synthetic female sex hormone


estrogen supplement drug used to relieve menopausal symptoms


A highly purified alpha interferon produced by a human lymphoid cell line. Interferon alpha-n1 consists of multiple alpha interferon subtypes, at least two of which are glycosylated. In contrast, recombinant alpha interferons are individual non-glycosylated proteins produced from individual alpha interferon genes. Alpha interferons bind to specific cell-surface receptors, resulting in the transcription and translation of genes whose proteins have antiviral, antiproliferative, anticancer, and immune-modulating effects. (NCI04)


A standardized, concentrated preparation, by Purdue, containing the anthraquinone glycosides sennosides extracted from senna leaves with laxative activity. Sennosides act on and irritate the lining of the intestine wall, thereby causing increased intestinal muscle contractions leading to vigorous bowel movement.


The sodium salt of pentobarbital, a short-acting barbituric acid derivative with central nervous system (CNS) depressant property. Pentobarbital sodium binds to the gamma-aminobutyric acid (GABA)-A subtype receptor, resulting in modulation of chloride transport through receptor channels and potentiation of GABA-induced increases in chloride conductance. This enhances postsynaptic responses to the inhibitory actions of GABA and causes CNS depression. In addition, this agent inhibits glutamate induced nerve depolarization and depresses voltage-activated calcium currents.


chlordiazePOXIDE hydrochloride 25 MG Oral Tablet

chlordiazepoxide hydrochloride 25 MG Oral Tablet


chlordiazePOXIDE hydrochloride 5 MG Oral Tablet

chlordiazepoxide hydrochloride 5 MG Oral Tablet


chlordiazePOXIDE hydrochloride 10 MG Oral Tablet

chlordiazepoxide hydrochloride 10 MG Oral Tablet


hydrocortisone 0.01 MG/MG Topical Ointment


The hydrochloride salt of an iodine-rich benzofuran derivative with antiarrhythmic and vasodilatory activities. As a class III antiarrhythmic agent, amiodarone blocks the myocardial calcium, potassium and sodium channels in cardiac tissue, resulting in prolongation of the cardiac action potential and refractory period. In addition, this agent inhibits alpha- and beta-adrenergic receptors, resulting in a reduction in sympathetic stimulation of the heart, a negative chronotropic effect, and a decrease in myocardial oxygen demands. Amiodarone may cause vasodilation by stimulation of the release of nitric oxide and cyclooxygenase-dependent relaxing endothelial factors.


The trihydrate form of ampicillin, a broad-spectrum semisynthetic derivative of aminopenicillin. Ampicillin trihydrate inhibits bacterial cell wall synthesis by binding to penicillin binding proteins, thereby inhibiting peptidoglycan synthesis, a critical component of the bacterial cell wall.


The hydrochloride salt of an anxiolytic agent chemically and pharmacologically unrelated to benzodiazepines, barbiturates, or other sedative/hypnotic drugs. Although its exact mechanism of action is unknown, buspirone may exert its anti-anxiety effects via serotonin (5-HT1A) and dopamine receptors (D2) and may indirectly affect other neurotransmitter systems. Unlike typical benzodiazepine anxiolytics, this agent does not exert anticonvulsant or muscle relaxant effects and lacks prominent sedative effects.


The sodium salt form of cefotaxime, a beta-lactam, third-generation cephalosporin antibiotic with bactericidal activity. Cefotaxime sodium binds to and inactivates penicillin-binding proteins (PBP) located on the inner membrane of the bacterial cell wall. Inactivation of PBPs interferes with the cross-linking of peptidoglycan chains necessary for bacterial cell wall strength and rigidity. This results in the weakening of the bacterial cell wall and causes cell lysis. Compared to the second and first generation cephalosporins, cefotaxime sodium is more active against gram-negative bacteria and less active against gram-positive bacteria.


The sodium salt form of cefoxitin, a beta-lactam, second-generation cephalosporin antibiotic with bactericidal activity. Cefoxitin sodium binds to and inactivates penicillin-binding proteins (PBP) located on the inner membrane of the bacterial cell wall. PBPs participate in the terminal stages of assembling the bacterial cell wall, and in reshaping the cell wall during cell division. Inactivation of PBPs interferes with the cross-linkage of peptidoglycan chains necessary for bacterial cell wall strength and rigidity. This results in the weakening of the bacterial cell wall and causes cell lysis.


The sulfate salt of chloroquine, a quinoline compound with antimalarial and anti-inflammatory properties. Chloroquine is the most widely used drug against malaria, except for those cases caused by chloroquine resistant Plasmodium falciparum. Although the mechanism of action is not fully understood, chloroquine is shown to inhibit the parasitic enzyme heme polymerase that converts the toxic heme into non-toxic hemazoin, thereby resulting in the accumulation of toxic heme within the parasite. Chloroquine may also interfere with the biosynthesis of nucleic acids.


The hydrochloride salt form of dobutamine, a synthetic catecholamine with direct inotropic activity. Dobutamine hydrochloride, mimics the effects of dopamine and stimulates beta-1 adrenergic receptors located in the myocardium. This leads to an increase in heart rate and force and results in an increase in cardiac output.


The maleate salt form of enalapril, a dicarbocyl-containing peptide and angiotensin-converting enzyme (ACE) inhibitor with antihypertensive activity. As a prodrug, enalapril is converted by de-esterification into its active form enalaprilat. Enalaprilat competitively binds to and inhibits ACE, thereby blocking the conversion of angiotensin I to angiotensin II. This prevents the potent vasoconstrictive actions of angiotensin II and results in vasodilation. Enalapril also decreases angiotensin II-induced aldosterone secretion by the adrenal cortex, which leads to an increase in sodium excretion and subsequently increases water outflow.


Fenoterol BromideThe hydrobromide salt of fenoterol, a short-acting sympathomimetic agent with bronchodilator activity. Fenoterol stimulates beta-2-adrenergic receptors in the lungs, thereby activating the enzyme adenylate cyclase that catalyzes the conversion of adenosine triphosphate (ATP) to cyclic-3',5'-adenosine monophosphate (cAMP). Increased cAMP concentrations relax bronchial smooth muscle, relieve bronchospasms, and reduce inflammatory cell mediator release, especially from mast cells.


The hydrochloride salt form of maprotiline, a tetracyclic antidepressant closely related to the tricyclic antidepressants with adrenergic activity and sedative properties. Maprotiline hydrochloride exerts its effect by blocking the re-uptake of norepinephrine, thereby increasing the synaptic concentration of norepinephrine in the central nervous system and subsequently prolonging the action of norepinephrine on central receptors.


The hydrochloride salt of a short-acting benzodiazepine derivative with an imidazole structure and anxiolytic, amnestic, hypnotic, anticonvulsant and sedative properties. Midazolam binds to the benzodiazepine receptor at the gamma-aminobutyric acid (GABA) receptor-chloride ionophore complex in the central nervous system (CNS), resulting in increases in the opening of chloride channels, membrane hyperpolarization, and the inhibitory effect of GABA. This agent may also interfere with the reuptake of GABA, thereby causing accumulation of GABA in the synaptic cleft.


The hydrochloride salt of an anthracenedione antibiotic with antineoplastic activity. Mitoxantrone intercalates into and crosslinks DNA, thereby disrupting DNA and RNA replication. This agent also binds to topoisomerase II, resulting in DNA strand breaks and inhibition of DNA repair. Mitoxantrone is less cardiotoxic compared to doxorubicin.


The hydrochloride salt form of nortriptyline, a tricyclic antidepressant agent used for short-term treatment of various forms of depression. Nortriptyline blocks the norepinephrine presynaptic receptors, thereby blocking the reuptake of this neurotransmitter and raising the concentration in the synaptic cleft in the CNS. Nortriptyline also binds to alpha-adrenergic, histaminergic and cholinergic receptors. Long-term treatment with nortriptyline produces a downregulation of adrenergic receptors due to the increased stimulation of these receptors.


The hydrochloride salt form of oxprenolol, a lipophilic, nonselective beta-adrenergic receptor antagonist with anti-arrhythmic, anti-anginal and antihypertensive activities. Oxprenolol competitively binds to and blocks beta-1 adrenergic receptors in the heart, thereby decreasing cardiac contractility and rate. This leads to a reduction in cardiac output and lowers blood pressure. In addition, oxprenolol prevents the release of renin, a hormone secreted by the kidneys that causes constriction of blood vessels.


The hydrochloride salt of the opiate alkaloid isolated from the plant Papaver somniferum and produced synthetically. As a direct-acting smooth muscle relaxant, papaverine is not closely related to the other opium alkaloids in structure or pharmacological actions; its mechanism of action may involve the non-selective inhibition of phosphodiesterases and direct inhibition of calcium channels. This agent also exhibits antiviral activity against respiratory syncytial virus, cytomegalovirus, and HIV. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C80006" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C80006" NCI Thesaurus)


The potassium salt form of penicillin G, a broad-spectrum penicillin antibiotic. Penicillin G potassium binds to penicillin binding proteins (PBP), the enzymes that catalyze the synthesis of peptidoglycan, which is a critical component of the bacterial cell wall. This leads to the interruption of cell wall synthesis, consequently leading to bacterial cell growth inhibition and cell lysis.


The sodium salt of piperacillin, a broad-spectrum semisynthetic, ampicillin-derived ureidopenicillin antibiotic with bactericidal activity. Piperacillin binds to and inactivates penicillin-binding proteins (PBPs), enzymes located on the inner membrane of the bacterial cell wall, resulting in the weakening of the bacterial cell wall and cell lysis. PBPs participate in the terminal stages of assembling the bacterial cell wall, and in reshaping the cell wall during cell division. Inactivation of PBPs interferes with the cross-linkage of peptidoglycan chains necessary for bacterial cell wall strength and rigidity.


The hydrochloride salt form of propafenone with class 1C antiarrhythmic effects. Propafenone hydrochloride stabilizes the neuronal membrane by binding to and inhibiting voltage-gated sodium channels, thereby reducing sodium influx required for the initiation and conduction of impulses in Purkinje and myocardial cells. This agent produces a marked depression of phase 0 and prolonged effective refractory period in the atrio-ventricular nodal and His-Purkinje tissue, resulting in a profound decrease in excitability, conduction velocity and automaticity, thereby counteracting atrial and ventricular arrythmias.


A member of the class of histamine H2-receptor antagonists with antacid activity. Ranitidine is a competitive and reversible inhibitor of the action of histamine, released by enterochromaffin-like (ECL) cells, at the histamine H2-receptors on parietal cells in the stomach, thereby inhibiting the normal and meal-stimulated secretion of stomach acid. In addition, other substances that promote acid secretion have a reduced effect on parietal cells when the H2 receptors are blocked.


The hydrochloride salt form of selegiline, a levorotatory acetylenic derivative of phenethylamine with antiparkinsonian effect. As a selective monoamine oxidase (MAO) inhibitor, selegiline has the greatest affinity for type B MAO, found mainly in the brain. Selegiline is converted by MAO B to an active moiety, which binds irreversibly at the active site of the enzyme's cofactor FAD (flavin adenine dinucleotide) molecule. This prevents the oxidative deamination of catecholamines and serotonin by MAO B, and leads to an increase in these neurotransmitters' activities resulting in improved motor function. In addition, this agent may inhibit re-uptake of dopamine by the neuron and prolong dopamine activity.


The hydrochloride form of Verapamil, which is a phenylalkylamine calcium channel blocking agent. Verapamil inhibits the transmembrane influx of extracellular calcium ions into myocardial and vascular smooth muscle cells, causing dilatation of the main coronary and systemic arteries and decreasing myocardial contractility. This agent also inhibits the drug efflux pump P-glycoprotein which is overexpressed in some multi-drug resistant tumors and may improve the efficacy of some antineoplastic agents. (NCI04)


The sodium salt form of cefmetazole, a second-generation, semi-synthetic, beta-lactam cephalosporin antibiotic with antibacterial activity. Cefmetazole binds to penicillin-binding proteins (PBPs), transpeptidases that are responsible for crosslinking of peptidoglycan. By preventing crosslinking of peptidoglycan, cell wall integrity is lost and cell wall synthesis is halted.


The disodium salt form of cefotetan and a semi-synthetic, broad-spectrum, beta-lactamase-resistant, second-generation cephalosporin antibiotic with bactericidal activity. Cefotetan disodium causes inhibition of bacterial cell wall synthesis by inactivating penicillin binding proteins (PBPs) thereby interfering with the final transpeptidation step required for cross-linking of peptidoglycan units which are a component of the cell wall. This results in a reduction of cell wall stability and causes cell lysis.


The hydrochloride salt form of guanfacine, a centrally acting alpha-2 adrenergic agonist with antihypertensive activity. Alpha-2 receptor stimulation by guanfacine hydrochloride results in a decreased sympathetic outflow from the vasomotor center to the heart, kidneys, and peripheral vasculature. This leads to a decrease in heart rate and peripheral vascular resistance. (NCI05)


The maleate salt form of fluvoxamine, a 2-aminoethyl oxime ether of aralkylketones, with antidepressant, antiobsessive-compulsive, and antibulimic activities. Fluvoxamine blocks serotonin reuptake by inhibiting the serotonin reuptake pump of the presynaptic neuronal membrane leading to an increase of serotonin levels within the synaptic cleft. This results in facilitated serotonergic transmission and decreased serotonin turnover leading to antidepressant and antiobsessive-compulsive effects.


The sodium salt of pravastatin with cholesterol-lowering and potential antineoplastic activities. Pravastatin competitively inhibits hepatic hydroxymethyl-glutaryl coenzyme A (HMG-CoA) reductase, the enzyme which catalyzes the conversion of HMG-CoA to mevalonate, a key step in cholesterol synthesis. This agent lowers plasma cholesterol and lipoprotein levels, and modulates immune responses by suppressing MHC II (major histocompatibility complex II) on interferon gamma-stimulated, antigen-presenting cells such as human vascular endothelial cells. In addition, pravastatin, like other statins, exhibits pro-apoptotic, growth inhibitory, and pro-differentiation activities in a variety of tumor cells; these antineoplastic activities may be due, in part, to inhibition of the isoprenylation of Ras and Rho GTPases and related signaling cascades.


The acetate salt of a synthetic decapeptide analog of luteinizing hormone-releasing hormone (LHRH). Continuous, prolonged administration of goserelin in males results in inhibition of pituitary gonadotropin secretion, leading to a significant decline in testosterone production; in females, prolonged administration results in a decrease in estradiol production. (NCI04)


The acetate salt form of nafarelin, a modified synthetic porcine luteinizing hormone (LH)-releasing hormone peptide analog, with gonadotropin-releasing hormone (GnRH) agonist activity. Upon nasal inhalation, nafarelin acetate binds to the GnRH receptor. This initially results in the release of the gonadotropins, follicle-stimulating hormone (FSH) and LH, from the pituitary gland; however, prolonged stimulation of the GnRH receptor desensitizes the receptor, which leads to decreased secretion of FSH and LH. In females, the inhibition of gonadotropin secretion causes hypogonadotropic hypogonadism leading to decreased production of estrogen and progesterone and anovulation. In males, the inhibition of LH secretion prevents the production and release of testosterone from Leydig cells in the testes and causes a significant decline in testosterone production that is near the levels seen following castration.


The hydrochloride salt of the racemic form of ondansetron, a carbazole derivative and a selective, competitive serotonin 5-hydroxytryptamine type 3 (5-HT3) receptor antagonist with antiemetic activity. Although its mechanism of action has not been fully characterized, ondansetron appears to competitively block the action of serotonin at 5HT3 receptors peripherally in the gastrointestinal tract as well as centrally in the area postrema of the CNS, where the chemoreceptor trigger zone (CTZ) for vomiting is located, resulting in the suppression of chemotherapy- and radiotherapy-induced nausea and vomiting.


A synthetic phenylmethyl-piperazinyl derivative, antihistaminic Cetirizine is a metabolite of hydroxyzine and a selective peripheral histamine H1-receptor antagonist. It is used for symptomatic treatment of seasonal and perennial allergic rhinitis and for chronic urticaria. (NCI04)


The mesylate salt form of fenoldopam, a benzazepine derivative with rapid-acting vasodilator activity. Fenoldopam mesylate is a racemic mixture of S- and R- isomers; the latter is responsible for the biological activity and has a significantly higher affinity for dopamine D1-like receptors (D1 and D5) as well as moderate affinity to alpha-2 adrenergic receptors. This agent selectively activates the dopamine D1-like receptor, thereby causing vasodilatation and increasing renal perfusion.


The sodium salt of alendronate, a second generation bisphosphonate and synthetic analog of pyrophosphate with bone anti-resorption activity. Alendronate sodium binds to and inhibits the activity of geranyltranstransferase (farnesyl pyrophosphate synthetase), an enzyme involved in terpenoid biosynthesis. Inhibition of this enzyme prevents the biosynthesis of isoprenoid lipids (FPP and GGPP) that are donor substrates of farnesylation and geranylgeranylation during the post-translational modification of small GTPase signalling proteins, which is important in the process of osteoclast turnover. As a result, osteoclast activity is inhibited and bone resorption and turnover are reduced.


A synthetic antiviral agent. Indinavir selectively binds to the active site of human immunodeficiency virus (HIV) protease and inhibits its activity, preventing the protease-mediated cleavage of gag-pol viral polyproteins; as a result immature, noninfectious virions are produced.


An ester with sympathomimetic activities. Dipivefrin hydrochloride is a prodrug of epinephrine that, due to its greater lipophilicity, allows for better penetration into the anterior chamber. Once inside the eye, dipivefrin hydrochloride is converted by hydrolysis to epinephrine. Epinephrine enhances the outflow of aqueous humor and decreases the production of aqueous humor by vasoconstriction. This leads to a reduction in intraocular pressure.


The potassium salt of losartan, a non-peptide angiotensin II receptor antagonist with antihypertensive activity. Losartan selectively and competitively binds to the angiotensin II receptor (type AT1) and blocks the binding of angiotensin II to the receptor, thus promoting vasodilatation and counteracting the effects of aldosterone. Converted from angiotensin I by angiotensin-converting enzyme (ACE), angiotensin II stimulates the adrenal cortex to synthesize and secrete aldosterone, decreasing sodium excretion and increasing potassium excretion, and acts as a vasoconstrictor in vascular smooth muscle.


The sulfosalicylate salt form of meclocycline, a tetracycline antibiotic with broad-spectrum antibacterial and antiprotozoal activity. Meclocycline sulfosalicylate is bacteriostatic and inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit, thereby preventing the addition of amino acids to the growing peptide chain. This tetracycline is active against a wide range of gram-positive and gram-negative bacteria.


The hydrochloride salt form of pyridoxine, a water-soluble vitamin B. Pyridoxine hydrochloride is converted into the active form, pyridoxal 5'-phosphate (PLP), an essential cofactor in many enzymatic activities including synthesis of amino acids, neurotransmitters, and sphingolipids. This vitamin is essential to red blood cell, nervous system, and immune systems functions and helps maintain normal blood glucose levels.


The hydrochloride salt form of thioridazine, a piperidine phenothiazine derivative and a dopamine antagonist with antipsychotic property. Thioridazine hydrochloride binds to mesolimbic postsynaptic dopamine receptor D2, thereby decreasing dopamine activity leading to decreased psychotic effects, such as hallucinations and delusions. In addition, this agent binds to serotonin 5-HT2 receptors, resulting in decreased serotonin activity.


The hydrochloride salt of the tricyclic dibenzocycloheptadiene amitriptyline with antidepressant and antinociceptive activities. Amitriptyline inhibits the re-uptake of norepinephrine and serotonin by the presynaptic neuronal membrane in the central nervous system (CNS), thereby increasing the synaptic concentration of norepinephrine and serotonin. Due to constant stimulation to these receptors, amitriptyline may produce a downregulation of adrenergic and serotonin receptors, which may contribute to the antidepressant activity. In the CNS the antinociceptive activity of this agent may involve high affinity binding to and inhibition of N-methyl-D-aspartate (NMDA) receptors and/or the enhancement of the action of serotonin at the spinal terminals of an opioid-mediated intrinsic analgesia system.


The sodium salt of cefazolin, a beta-lactam antibiotic and first-generation cephalosporin with bactericidal activity. Cefazolin binds to and inactivates penicillin-binding proteins (PBP) located on the inner membrane of the bacterial cell wall. Inactivation of PBPs interferes with the cross-linkage of peptidoglycan chains necessary for bacterial cell wall strength and rigidity, which results in the weakening of the bacterial cell wall and cell lysis.


The sodium salt form of ceftriaxone, a beta-lactam, third-generation cephalosporin antibiotic with bactericidal activity. Ceftriaxone binds to and inactivates penicillin-binding proteins (PBP) located on the inner membrane of the bacterial cell wall. PBPs participate in the terminal stages of assembling the bacterial cell wall, and in reshaping the cell wall during cell division. Inactivation of PBPs interferes with the cross-linkage of peptidoglycan chains necessary for bacterial cell wall strength and rigidity. This results in the weakening of the bacterial cell wall and causes cell lysis. Compared to the second and first generation cephalosporins, ceftriaxone is more active against gram-negative bacteria and less active against gram-positive bacteria. Ceftriaxone also crosses the blood-brain barrier and reaches therapeutic concentrations in the central nervous system (CNS).


The hydrochloride salt form of chlordiazepoxide, a long-acting benzodiazepine with anxiolytic, sedative and hypnotic activity. Chlordiazepoxide hydrochloride exerts its effect by binding to the benzodiazepine site at the gamma-aminobutyric acid (GABA) receptor-chloride ionophore complex in the central nervous system (CNS). This leads to an increase in the opening of chloride channels, membrane hyperpolarization, and increases the inhibitory effect of GABA on the CNS.


The hydrochloride salt form of desipramine, a secondary amine tricyclic antidepressant (TCA). In the central nervous system (CNS), desipramine hydrochloride blocks the re-uptake of neurotransmitters, including norepinephrine and serotonin. This leads to an increase in the amount of these neurotransmitters in the synaptic cleft and prolongs their activities postsynaptically.


An ergot derivative with agonistic activity for alpha-adrenergic, serotonergic, and dopaminergic receptors. Dihydroergotamine mesylate most likely relieves migraine headaches by binding to and stimulating the 5-HT1D receptor subtype, thereby causing constriction of cerebral blood vessels. However, it has also been proposed that dihydroergotamine mesylate acts upon 5-HT1D receptors on sensory nerve endings of the trigeminal system, thereby decreasing the release of pro-inflammatory neuropeptide release.


The hydrochloride salt form of hydromorphone, the hydrogenated ketone of morphine, a semi-synthetic opioid with analgesic effects. Hydromorphone selectively binds the mu-opioid receptor which is linked through G-proteins. Binding stimulates the exchange of guanosine triphosphate (GTP) for guanosine diphosphate (GDP) on the G-protein complex and interacts with and inhibits adenylate cyclase located at the inner surface of the plasma membrane. This leads to a reduction in intracellular cyclic 3',5'-adenosine monophosphate (cAMP). Further, voltage-gated potassium channels are activated, thereby causing hyperpolarization and reducing neuronal excitability. In addition, the opening of voltage-gated calcium channels is inhibited, thereby leading to an inhibition of calcium entry and a reduction in the release of various neurotransmitters, including GABA, vasopressin, somatostatin, insulin and glucagons.


A class Ia antiarrhythmic agent with cardiac depressant properties. Disopyramide phosphate exerts its actions by blocking both sodium and potassium channels in cardiac membrane during phase 0 of the action potential. This slows the impulse conduction through the AV node and prolongs the duration of the action potential of normal cardiac cells in atrial and ventricular tissues. Disopyramide prolongs the QT interval and causes a widening of the QRS complex. It also possesses some anticholinergic and local anaesthetic properties. Disopyramide phosphate is used in the treatment of supraventricular tachycardia.


A dibenzoxepin derivative and tricyclic antidepressant with antipruritic and sedative activities. Doxepin blocks the reuptake of norepinephrine and serotonin into presynaptic terminals thereby prolonging the availability of the monoaminergic neurotransmitters within the synaptic cleft and enhancing their action leading to sedative effects. Doxepin also has antagonistic effects on histamine (H1 and H2), 5-HT2, alpha-1 adrenergic, and muscarinic receptors. The antipruritic effect of this agent is the result mediated through inhibition of histamine receptors.


The bitartrate salt form of epinephrine, a direct-acting sympathomimetic amine with bronchodilator and vasoconstricting activity. Epinephrine bitartrate acts on both alpha and beta adrenergic receptors. By stimulating alpha adrenergic receptors locally, this agent causes vasoconstriction and reduces vascular blood flow. Administered in the conjunctiva, epinephrine bitartrate induces vasoconstriction and decreases the production of aqueous humor mediated through alpha-adrenergic receptors. Through its beta-stimulating actions, this agent relaxes bronchial smooth muscle and causes bronchodilation.


The pamoate salt form of hydroxyzine, a synthetic piperazine histamine H1-receptor antagonist with anti-allergic, antispasmodic, sedative, anti-emetic and anti-anxiety properties. Hydroxyzine pamoate blocks the H1 histamine receptor and prevents the symptoms that are caused by histamine activity on capillaries, bronchial smooth muscle, and gastrointestinal smooth muscle, including vasodilatation, increased capillary permeability, bronchoconstriction, and spasmodic contraction of gastrointestinal smooth muscle. In addition, hydroxyzine pamoate crosses the blood-brain barrier and acts on the histamine H1-receptors in the central nervous system. (NCI05)


The sulfate salt of kanamycin, a naturally occurring aminoglycoside antibiotic with antimicrobial property. Derived from Streptomyces kanamyceticus, kanamycin is an antibiotic complex consisting of three components: kanamycin A, the major component (also usually designated as kanamycin), and kanamycins B and C, the minor components. This agent irreversibly binds to the bacterial 30S ribosomal subunit. Specifically, this antibiotic is lodged between 16S rRNA and S12 protein within the 30S subunit. This leads to interference with translational initiation complex, misreading of mRNA, thereby hampering protein synthesis and resulting in bactericidal effect. Aminoglycosides are mostly ineffective against anaerobic bacteria, fungi and viruses.


The hydrochloride salt of a synthetic derivative of cyclohexanone with analgesic and anesthetic activities. Although its mechanism of action is not well understood, ketamine appears to non-competitively block N-methyl-D-aspartate (NMDA) receptors and may interact with opioid mu receptors and sigma receptors, thereby reducing pain perception, inducing sedation, and producing dissociative anesthesia.


The hydrochloride salt form of mepivacaine, an amide derivative with local anesthetic properties. At the injection site, mepivacaine hydrochloride acts by binding to specific membrane sodium ion channels in the neuronal cell membranes, thereby inhibiting sodium influx. This leads to a blockage of nerve impulse conduction and results in a loss of sensation.


The hydrochloride salt of the synthetic central nervous system stimulant methylphenidate. Methylphenidate appears to activate the brain stem arousal system and cortex to produce its stimulant effect and, in some clinical settings, may improve cognitive function.


The sodium succinate salt of a synthetic glucocorticoid receptor agonist with immunosuppressive and anti-inflammatory effects. Methylprednisolone sodium succinate is converted into active prednisolone in the body, which activates glucocorticoid receptor mediated gene expression. This includes inducing synthesis of anti-inflammatory protein IkappaB-alpha and inhibiting synthesis of nuclear factor kappaB (NF-kappaB). As a result, proinflammatory cytokine production such as IL-1, IL-2 and IL-6 is down-regulated and cytotoxic T-lymphocyte activation is inhibited. Therefore, an overall reduction in chronic inflammation and autoimmune reactions may be achieved.


The tartrate salt form of metoprolol, a cardioselective competitive beta-1 adrenergic receptor antagonist with antihypertensive properties and devoid of intrinsic sympathomimetic activity. Metoprolol tartrate antagonizes beta 1-adrenergic receptors in the myocardium, thereby reducing the rate and force of myocardial contraction, and consequently a diminished cardiac output. This agent may also reduce the secretion of renin with subsequent reduction in levels of angiotensin II thus decreasing sympathetic activation, including vasoconstriction, aldosterone secretion.


The hydrochloride salt of naloxone, a thebaine derivate with opioid antagonist activity. Naloxone binds to opioid receptors in the CNS in a competitive manner, reversing or inhibiting characteristic opioid effects, including analgesia, euphoria, sedation, respiratory depression, miosis, bradycardia, and physical dependence. This agent binds to mu-opioid receptors with a high affinity, and a lesser degree to kappa- and gamma-opioid receptors.


The sulfate salt form of netilimicin, a semisynthetic, water soluble aminoglycoside antibiotic. Netilmicin is derived from sisomicin, a naturally occurring aminoglycoside antibiotic produced by the fermentation of Micromonospora inyoensis. Netilmicin irreversibly binds to the 16S rRNA and S12 protein of the bacterial 30S ribosomal subunit. As a result, this agent interferes with the assembly of initiation complex between mRNA and the bacterial ribosome, thereby inhibiting the initiation of protein synthesis. In addition, netilmicin induces misreading of the mRNA template and causes translational frameshift, thereby results in premature termination. This eventually leads to bacterial cell death.


Sodium salt of aminohippuric acid. Aminohippurate sodium is used as a non-toxic diagnostic tool to measure effective renal plasma flow. At low plasma concentration this agent is filtered by the glomeruli and almost completely cleared from the renal blood stream by active tubular secretion in a single transit through the kidney. Its clearance corresponds to the renal plasma blood flow. Aminohippurate sodium is also used to measure functional capacity of the renal tubular secretory mechanism. This is achieved by elevating the drug plasma concentration to levels sufficient to saturate the maximal secretion capacity of the tubular cells.


The potassium salt of penicillin V, a member of the penicillin antibiotic family with broad-spectrum bactericidal activity. Penicillin V binds to and inactivates penicillin-binding proteins (PBPs), enzymes located on the inner membrane of the bacterial cell wall, resulting in the weakening of the bacterial cell wall and cell lysis. PBPs participate in the terminal stages of assembling the bacterial cell wall, and in reshaping the cell wall during cell division. Inactivation of PBPs interferes with the cross-linkage of peptidoglycan chains necessary for bacterial cell wall strength and rigidity.


A synthetic, brick-red crystalline solid that is only slightly soluble in cold water and ethanol but is soluble in boiling water, acetic acid, glycerol, ethylene glycol and propylene glycol. It is used orally as a urinary tract analgesic. Side effects of phenazopyridine hydrochloride administration can include nausea, interference with the oxygen-carrying capacity of red blood cells (methemoglobinemia), hemolytic anemia as well as renal and hepatic toxicity. It is reasonably anticipated to be a human carcinogen. (NCI05)


The hydrochloride salt form of protriptyline, a tricyclic secondary amine with antidepressant property. Protriptyline hydrochloride blocks the re-uptake of norepinephrine and serotonin by nerve terminals, thereby increasing available norepinephrine and serotonin. Protriptyline does not block dopamine transport but may have an indirect dopamine-facilitating effect through interactions of increased peri-synaptic abundance of norepinephrine, particularly in the cerebral cortex, where adrenergic terminals exceed dopaminergic terminals. This results in elevation of mood and behavioral activity. In addition, this agent exhibits anticholinergic activity.


The hydrochloride salt of alfentanil, a synthetic short-acting opioid with analgesic and local anesthesia enhancing activity. Alfentanil primarily binds to mu-opioid receptor, a G-protein-coupled receptor, thereby mimicking the actions of morphine, the prototypical mu receptor agonist. This agent induces anti-nociception responses mediated through inhibiting the release of various neurotransmitters such as substance P, GABA, dopamine, acetylcholine and noradrenaline; in addition, the release of vasopressin, somatostatin, insulin and glucagon are also inhibited.


The hydrochloride salt of the aminoketone bupropion, with antidepressant activity and for potential use in promoting smoking cessation and improving sexual desire. Bupropion is a weak blocker of the neuronal uptake of serotonin, dopamine and norepinephrine and is a central nicotinic acetylcholine receptor antagonist.


The hydrochloride salt of fluphenazine, a phenothiazine with antipsychotic activity and potential antineoplastic activity. Fluphenazine blocks postsynaptic dopamine D2 receptors in the limbic system, cortical system and basal ganglia, resulting in a reduction of schizophrenia-associated hallucinations and delusions. In addition, as a serotonin antagonist, this agent may inhibit lymphocyte and myeloma cell proliferation by blocking 5-hydroxytrptamine type 1B (5-HT type 1B) receptors for serotonin.


A synthetic piperazine derivative with hypotensive antiadrenergic properties, Prazosin Hydrochloride reduces peripheral resistance and relaxes vascular smooth muscles as a selective adrenergic alpha-1 antagonist by a mechanism not completely known. It is used in the treatment of heart failure, hypertension, pheochromocytoma, Raynaud's syndrome, prostatic hypertrophy, and urinary retention. (NCI04)


A benzothiazepine calcium channel blocking agent. Diltiazem hydrochloride inhibits the transmembrane influx of extracellular calcium ions into select myocardial and vascular smooth muscle cells, causing dilatation of coronary and systemic arteries and decreasing myocardial contractility. Because of its vasodilatory activity, this agent has been shown to improve the microcirculation in some tumors, thereby potentially improving the delivery of antineoplastic agents to tumor cells. (NCI04)


The bromide salt form of ipratropium, a synthetic derivative of the alkaloid atropine with anticholinergic properties. Ipratropium antagonizes the actions of acetylcholine at parasympathetic, postganglionic, effector-cell junctions. When inhaled, ipratropium binds competitively to cholinergic receptors in the bronchial smooth muscle thereby blocking the bronchoconstrictor actions of the acetylcholine mediated vagal impulses. Inhibition of the vagal tone leads to dilation of the large central airways resulting in bronchodilation.


The hydrochloride salt of the 4'-epi-isomer of the anthracycline antineoplastic antibiotic doxorubicin. Epirubicin intercalates into DNA and inhibits topoisomerase II, thereby inhibiting DNA replication and ultimately, interfering with RNA and protein synthesis. This agent also produces toxic free-radical intermediates and interacts with cell membrane lipids causing lipid peroxidation.


The sodium salt form of diclofenac, a benzene acetic acid derivate and nonsteroidal anti-inflammatory drug (NSAID) with analgesic, antipyretic and anti-inflammatory activity. Diclofenac sodium is a non-selective reversible and competitive inhibitor of cyclooxygenase (COX), subsequently blocking the conversion of arachidonic acid into prostaglandin precursors. This leads to an inhibition of the formation of prostaglandins that are involved in pain, inflammation and fever.


The acetate salt of a synthetic nonapeptide analogue of gonadotropin-releasing hormone. Leuprolide binds to and activates gonadotropin-releasing hormone (GnRH) receptors. Continuous, prolonged administration of leuprolide in males results in pituitary GnRH receptor desensitization and inhibition of pituitary secretion of follicle stimulating hormone (FSH) and luteinizing hormone (LH), leading to a significant decline in testosterone production; in females, prolonged administration results in a decrease in estradiol production. This agent reduces testosterone production to castration levels and may inhibit androgen receptor-positive tumor progression.


A combination product containing pyrimethamine and sulfadoxine. Pyrimethamine is a competitive inhibitor of dihydrofolate reductase (DHFR). DHFR is a key enzyme in the redox cycle for production of tetrahydrofolate, a cofactor that is required for the synthesis of DNA and proteins. Sulfadoxine competitively antagonizes paraaminobenzoic acid (PABA), resulting in disruption of folic acid synthesis and ultimately DNA synthesis. Sulfadoxine acts synergistically with pyrimethamine. (NCI04)


An oil extracted from the seeds of the plant Oenothera biennis, a North American native biennial branching shrub with small yellow flowers. The oil contains the fatty acids linoleic acid and gamma-linolenic acid (GLA), a rare essential fatty acid.


The disodium salt of the 21-phosphate ester of betamethasone, a synthetic glucocorticoid with metabolic, immunosuppressive and anti-inflammatory actions. Betamethasone sodium phosphate binds to specific intracellular glucocorticoid receptors and subsequently binds to DNA to modify gene expression. The synthesis of certain anti-inflammatory proteins is induced while the synthesis of certain inflammatory mediators is inhibited. As a result, there is an overall reduction in chronic inflammation and autoimmune reactions.


The hydrochloride salt form of esmolol, a short and rapid-acting beta adrenergic antagonist belonging to the class II anti-arrhythmic drugs and devoid of intrinsic sympathomimetic activity. Esmolol hydrochloride competitively blocks beta-1 adrenergic receptors in cardiac muscle and reduces the contractility and cardiac rate of heart muscle, thereby decreasing cardiac output and myocardial oxygen demands. This agent also decreases sympathetic output centrally and blocks renin secretion. At higher doses, esmolol hydrochloride also blocks beta-2 receptors located in bronchial and vascular smooth muscle, thereby leading to smooth muscle relaxation.


Botox is a drug made from a toxin produced by the bacterium Clostridium botulinum. It's the same toxin that causes a life-threatening type of food poisoning called botulism. Doctors use it in small doses to treat health problems, including

Temporary smoothing of facial wrinkles and improving your appearance

Severe underarm sweating

Cervical dystonia - a neurological disorder that causes severe neck and shoulder muscle contractions

Blepharospasm - uncontrollable blinking

Strabismus - misaligned eyes

Chronic migraine

Overactive bladder

Botox injections work by weakening or paralyzing certain muscles or by blocking certain nerves. The effects last about three to twelve months, depending on what you are treating. The most common side effects are pain, swelling, or bruising at the injection site. You could also have flu-like symptoms, headache, and upset stomach. Injections in the face may also cause temporary drooping eyelids. You should not use Botox if you are pregnant or breastfeeding.


The sodium salt form of azlocillin, a semisynthetic, extended spectrum acylampicillin with antibacterial activity. Azlocillin binds to penicillin-binding proteins (PBPs) located inside the bacterial cell wall, thereby inhibiting the cross-linkage of peptidoglycans, which are critical components of the bacterial cell wall. This prevents proper bacterial cell wall synthesis, thereby results in the weakening of the bacterial cell wall and eventually leading to cell lysis.


The hydrochloride salt form of buprenorphine, a synthetic phenanthrene with narcotic analgesic activity. Buprenorphine hydrochloride is a partial agonist at the mu-opioid receptor and an antagonist at the kapa-opioid receptor in the central nervous system. However, under the conditions of recommended use it behaves as a classic mu-opioid agonist, mimicking the actions of endogenous peptides at CNS opioid receptors. The agonist action results in a raised pain threshold and increased tolerance to pain. However, it also causes sedation, physical dependence, and respiratory depressant effects and decreases heart rate and blood pressure.


metFORMIN hydrochloride 500 MG Oral Tablet [Glucophage]

metformin hydrochloride 500 MG Oral Tablet [Glucophage]


metFORMIN hydrochloride 850 MG Oral Tablet [Glucophage]

metformin hydrochloride 850 MG Oral Tablet [Glucophage]


hydrocortisone butyrate 0.001 MG/MG Topical Ointment [Locoid]


The sodium salt form of cefuroxime and a semi-synthetic, broad-spectrum, beta-lactamase resistant, second-generation cephalosporin antibiotic with bactericidal activity. Cefuroxime sodium inhibits bacterial cell wall synthesis by inactivating penicillin binding proteins (PBPs) thereby interfering with the final transpeptidation step required for cross-linking of peptidoglycan units which are a component of the cell wall. Lack of cross-linking results in a reduction of cell wall stability and leads to cell lysis.


brand name of carisoprodol, a muscle relaxant drug


dobutamine (as dobutamine HCl) 250 MG per 20 ML Injection

DOBUTamine (as DOBUTamine HCl) 250 MG per 20 ML Injection


chromic chloride 40 MCG per 10 ML Injection

chromium 40 MCG (as chromic chloride hexahydrate 20.5 MCG/ML) per 10 ML Injection

10 ML chromic chloride 0.004 MG/ML Injection


1 ML enalaprilat 1.25 MG/ML Injection
enalaprilat 1.25 MG per 1 ML Injection


immunoglobulin G, human 5 % in 10 ML Injection

immunoglobulin G, human 0.5 GM per 10 ML Injection

immunoglobulin G, human 5 % per 10 ML Injection

10 ML immunoglobulin G, human 50 MG/ML Injection


haloperidol 50 MG/ML (as haloperidol decanoate) Injectable Solution

haloperidol decanoate 50 MG/ML Injectable Solution


haloperidol 100 MG/ML (as haloperidol decanoate) Injectable Solution

haloperidol decanoate 100 MG/ML Injectable Solution


haloperidol 5 MG/ML (as haloperidol lactate) Injectable Solution


neomycin sulfate 0.35 % / polymyxin B sulfate 10,000 UNT/ML / hydrocortisone 1 % Otic Solution

hydrocortisone 1 % / neomycin (as neomycin sulfate) 0.35 % / polymyxin B (as polymyxin B sulfate) 10,000 UNT/ML Otic Solution

hydrocortisone 10 MG / neomycin 3.5 MG / polymyxin B 10,000 UNT per ML Otic Solution

hydrocortisone 10 MG/ML / neomycin 3.5 MG/ML / polymyxin B 10000 UNT/ML Otic Solution


hydroxyamphetamine HBr 1 % / tropicamide 0.25 % Ophthalmic Solution

hydroxyamphetamine 1 % / tropicamide 0.25 % Ophthalmic Solution

p-hydroxyamphetamine 10 MG/ML / tropicamide 2.5 MG/ML Ophthalmic Solution


INH 100 MG/ML Injectable Solution
isoniazid 100 MG/ML Injectable Solution


heparin sodium, porcine 2 UNT/ML Injectable Solution

heparin sodium, porcine 2 UNT/mL Injectable Solution


ibuprofen 50 MG in 1.25 mL Oral Suspension

ibuprofen 50 MG per 1.25 ML Oral Suspension Drops


interferon alfa-2b 6000000 UNT/ML Injectable Solution

interferon alfa-2b 6,000,000 UNT/ML Injectable Solution

interferon alfa-2b 3,000,000 UNT per 0.5 ML Injectable Solution


interferon alpha-n3 5,000,000 UNT/ML Injectable Solution

interferon alfa-n3 5000000 UNT/ML Injectable Solution


natamycin 50 MG/ML Ophthalmic Suspension


methyldopate hydrochloride 250 MG per 5 ML Injection

methyldopate HCl 250 MG in 5 ML Injection

5 ML methyldopate hydrochloride 50 MG/ML Injection


nefazodone hydrochloride 100 MG Oral Tablet


nefazodone hydrochloride 150 MG Oral Tablet


nefazodone hydrochloride 200 MG Oral Tablet


nefazodone hydrochloride 250 MG Oral Tablet


penicillin G benzathine 300000 UNT/ML / penicillin G procaine 300000 UNT/ML Injectable Suspension


hepatitis B surface antigen vaccine 2.5 MCG per 0.5 ML Injectable Suspension

hepatitis B surface antigen vaccine 5 MCG/ML Injectable Suspension

hepatitis B surface antigen vaccine 0.005 MG/ML Injectable Suspension


niCARdipine HCl 40 MG in 200 ML Injection

nicardipine hydrochloride 40 MG per 200 ML Injection

niCARdipine hydrochloride 40 MG per 200 ML Injection

200 ML niCARdipine hydrochloride 0.2 MG/ML Injection

200 ML nicardipine hydrochloride 0.2 MG/ML Injection


hepatitis B surface antigen vaccine 40 MCG in 1 ML Injection

hepatitis B vaccine (recombinant) dialysis formulation (HepB) 40 MCG in 1 ML Injection

1 ML hepatitis B surface antigen vaccine 0.04 MG/ML Injection


sodium tetradecyl sulfate 1 % Injectable Solution

sodium tetradecyl sulfate 10 MG/ML Injectable Solution


sodium tetradecyl sulfate 3 % Injectable Solution

sodium tetradecyl sulfate 30 MG/ML Injectable Solution


DES 1 MG Oral Tablet
diethylstilbestrol 1 MG Oral Tablet


DES 5 MG Oral Tablet
diethylstilbestrol 5 MG Oral Tablet


hydroCHLOROthiazide 25 MG / reserpine 0.125 MG Oral Tablet

HCTZ 25 MG / reserpine 0.125 MG Oral Tablet

reserpine 0.125 MG / hydroCHLOROthiazide 25 MG Oral Tablet

hydrochlorothiazide 25 MG / reserpine 0.125 MG Oral Tablet


digoxin 100 MCG in 1 ML Injection
digoxin 100 MCG per 1 ML Injection


flumazenil 0.1 MG/ML Injectable Solution


polymyxin B 250000 UNT/ML Injectable Solution

polymyxin B Variable Concentration Multi-Use Injectable Solution


potassium chloride 2 MEQ/ML Injectable Solution

potassium chloride 2 MEQ/mL Injectable Solution

potassium chloride 15 % Injectable Solution

K+ Chloride 2 MEQ/ML Injectable Solution

Pot Chloride 2 MEQ/ML Injectable Solution


cytomegalovirus immune globulin, human 2.5 GM in 50 mL Injection

cytomegalovirus immune globulin, human 2500 MG per 50 ML Injection

cytomegalovirus immune globulin, human 2.5 GM per 50 ML Injection

50 ML cytomegalovirus immune globulin, human 50 MG/ML Injection


zidovudine 200 MG in 20 ML Injection
20 ML zidovudine 10 MG/ML Injection
zidovudine 200 MG per 20 ML Injection


copper (as cupric chloride) 0.4 MG/ML Injectable Solution

cupric chloride 1.07 MG/ML (copper 0.4 MG/ML) Injectable Solution

cupric chloride 1.07 MG/ML Injectable Solution


pneumococcal 23-valent polysaccharide vaccine (PPSV23) Injectable Solution

pneumococcal capsular polysaccharides (23) 0.5 ML Injectable Solution

Streptococcus pneumoniae type 1 capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 10A capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 11A capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 12F capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 14 capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 15B capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 17F capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 18C capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 19A capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 19F capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 2 capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 20 capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 22F capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 23F capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 3 capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 33F capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 4 capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 5 capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 6B capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 7F capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 8 capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 9N capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 9V capsular polysaccharide antigen 0.05 MG/ML Injectable Solution


EPINEPHrine 0.01 MG/ML / lidocaine hydrochloride 10 MG/ML Injectable Solution

lidocaine HCl 1 % / EPINEPHrine 1:100,000 Injectable Solution

EPINEPHrine (as EPINEPHrine bitartrate) 1:100,000 / lidocaine hydrochloride 1 % Injectable Solution

epinephrine (as epinephrine bitartrate) 1:100,000 / lidocaine hydrochloride 1 % Injectable Solution

epinephrine 0.01 MG/ML / lidocaine hydrochloride 10 MG/ML Injectable Solution


epinephrine 0.01 MG/ML / lidocaine hydrochloride 20 MG/ML Injectable Solution

EPINEPHrine 0.01 MG/ML / lidocaine hydrochloride 20 MG/ML Injectable Solution

EPINEPHrine 1:100,000 / lidocaine hydrochloride 2 % Injectable Solution

lidocaine HCl 2 % / EPINEPHrine 1:100,000 Injectable Solution

EPINEPHrine (as EPINEPHrine bitartrate) 1:100,000 / lidocaine hydrochloride 2 % Injectable Solution

epinephrine 1:100,000 / lidocaine hydrochloride 2 % Injectable Solution

epinephrine (as epinephrine bitartrate) 1:100,000 / lidocaine hydrochloride 2 % Injectable Solution


brompheniramine maleate 4 MG / phenylephrine HCl 10 MG Oral Tablet

brompheniramine maleate 4 MG / phenylephrine hydrochloride 10 MG Oral Tablet


methylcellulose 2 GM Powder for Oral Suspension

methylcellulose 2 GM Granules for Oral Suspension

methylcellulose 2000 MG Powder for Oral Suspension


bacitracin 400 UNT / neomycin 3.5 MG (as neomycin sulfate 5 MG) / polymyxin B 5000 UNT per GM Topical Ointment

bacitracin 0.4 UNT/MG / neomycin 0.0035 MG/MG / polymyxin B 5 UNT/MG Topical Ointment

bacitracin 400 UNT / neomycin 3.5 MG / polymyxin B 5000 UNT per GM Topical Ointment


riboflavin 25 MG Oral Tablet
vitamin B2 25 MG Oral Tablet


vitamin B2 50 MG Oral Tablet
riboflavin 50 MG Oral Tablet


riboflavin 100 MG Oral Tablet
vitamin B2 100 MG Oral Tablet


ferrous sulfate 200 MG (iron 40 MG) Oral Tablet


calcium carbonate 1500 MG (Ca 600 MG) Chewable Tablet

calcium carbonate 1500 MG (calcium 600 MG) Chewable Tablet

calcium carbonate 1500 MG Chewable Tablet


salicylic acid 2 % / sulfur 2 % Medicated Shampoo

salicylic acid 20 MG/ML / sulfur 20 MG/ML Medicated Shampoo


tyloxapol 0.25 % Ophthalmic Solution
tyloxapol 0.25 % Ophthalmic Drops


acetaminophen 650 MG / dextromethorphan hydrobromide 30 MG / pseudoephedrine hydrochloride 60 MG / pyrilamine maleate 50 MG per 30 ML Oral Solution

APAP 21.7 MG/ML / Dextromethorphan Hydrobromide 1 MG/ML / Pseudoephedrine Hydrochloride 2 MG/ML / Pyrilamine Maleate 1.66 MG/ML Oral Solution

acetaminophen 21.7 MG/ML / dextromethorphan hydrobromide 1 MG/ML / pseudoephedrine hydrochloride 2 MG/ML / pyrilamine maleate 1.66 MG/ML Oral Solution


allantoin 1 % / camphor 0.5 % / phenol 0.5 % Topical Ointment

allantoin 0.01 MG/MG / camphor 0.005 MG/MG / phenol 0.005 MG/MG Topical Ointment


milk of magnesia 2400 MG per 15 ML Oral Suspension

magnesium hydroxide 2400 MG in 15 mL Oral Suspension

magnesium hydroxide 2400 MG per 15 ML Oral Suspension

magnesium hydroxide 160 MG/ML Oral Suspension


pramoxine hydrochloride 1 % Topical Spray

pramoxine hydrochloride 10 MG/ML Topical Spray


dextromethorphan HBr 5 MG / guaiFENesin 50 MG / pseudoephedrine HCl 15 MG per 5 ML Oral Solution

dextromethorphan HBr 5 MG / guaiFENesin 50 MG / pseudoephedrine HCl 15 MG in 5 mL Oral Solution

dextromethorphan HBr 5 MG / guaifenesin 50 MG / pseudoephedrine HCl 15 MG per 5 ML Oral Solution

dextromethorphan hydrobromide 1 MG/ML / guaiFENesin 10 MG/ML / pseudoephedrine hydrochloride 3 MG/ML Oral Solution

dextromethorphan hydrobromide 1 MG/ML / guaifenesin 10 MG/ML / pseudoephedrine hydrochloride 3 MG/ML Oral Solution


povidone-iodine 0.047 MG/MG Topical Ointment


crude coal tar 2 % (coal tar solution 10 % ) Medicated Shampoo


APAP 660 MG / HYDROcodone bitartrate 10 MG Oral Tablet

APAP 660 MG / hydrocodone bitartrate 10 MG Oral Tablet

HYDROcodone bitartrate 10 MG / acetaminophen 660 MG Oral Tablet

acetaminophen 660 MG / HYDROcodone bitartrate 10 MG Oral Tablet

acetaminophen 660 MG / hydrocodone bitartrate 10 MG Oral Tablet


mesna 1 GM per 10 ML Injectable Solution


cefTRIAXone 500 MG (as cefTRIAXone sodium) Injection

ceftriaxone 500 MG (as ceftriaxone sodium) Injection


hydrocortisone 1 % / neomycin (neomycin sulfate) 0.35 % / polymyxin B (polymyxin B sulfate) 10,000 UNT/ML Ophthalmic Suspension

hydrocortisone 10 MG/ML / neomycin 3.5 MG/ML / polymyxin B 10000 UNT/ML Ophthalmic Suspension

neomycin sulfate 0.35 % / polymyxin B sulfate 10,000 UNT/ML / hydrocortisone 1 % Ophthalmic Suspension


potassium chloride 25 MEQ (1.875 GM) Powder for Oral Solution

potassium chloride 1.875 GM Powder for Oral Solution

potassium chloride 25 MEQ Powder for Oral Solution

K+ Chloride 25 MEQ Powder for Oral Solution

Pot Chloride 25 MEQ Powder for Oral Solution


aspirin 227 MG Chewing Gum
aspirin 227.5 MG Chewing Gum
ASA 228 MG Chewing Gum


cysteine 0.35 % / inositol 0.83 % / methionine 0.83 % / sodium propionate 0.5 % / urea 8.34 % Vaginal Cream

cysteine 3.5 MG/ML / inositol 8.3 MG/ML / methionine 8.3 MG/ML / sodium propionate 5 MG/ML / urea 83.4 MG/ML Vaginal Cream


acetaminophen 80 MG in 5 mL Oral Solution


arginine HCl 500 MG Oral Capsule
arginine 500 MG Oral Capsule


Iodine 50 MG/ML / K+ Iodide 100 MG/ML Oral Solution

Iodine 50 MG/ML / Pot Iodide 100 MG/ML Oral Solution

strong iodine (iodine 5 % / potassium iodide 10 % ) Oral Solution

iodine 50 MG/ML / potassium iodide 100 MG/ML Oral Solution


ZNO 0.25 MG/MG Paste
zinc oxide 25 % Paste


camphor 100 MG/ML Topical Solution
camphor spirit 10 % Topical Solution

camphor 10 % Concentrate for Topical Solution


fosfomycin (as fosfomycin tromethamine) 3000 MG Powder for Oral Solution

fosfomycin 3 GM Powder for Oral Solution

fosfomycin 3 GM Granule for Oral Solution

fosfomycin 3000 MG Powder for Oral Solution


salicylic acid 30 MG/ML Medicated Shampoo